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ABSTRACT
The Smad proteins transduce the signal of transforming growth factor-p (TGF-P)
and related factors from the cell surface to the nucleus. Following C-terminal
phosphorylation by a corresponding receptor kinase, the R-Smad proteins form
heteromeric complexes with Smad4. These complexes translocate into the nucleus, bind
specific transcriptional activators and DNA, ultimately modulating gene expression.
Though studied through a varety of means, the stoichiometr of the R-Smad/Smad4
complex is unclear. We investigated the stoichiometry of the phosphorylation-induced
Smad/Smad4 complex by using acidic amino acid substitutions to simulate
phosphorylatio . Size exclusion chromatography, analytical ultracentrfugation, and
isothermal titration calorimetry analysis revealed that the R-Smad/Smad4 complex is a
heterotrmer consisting of two R-Smad subunits and one Smad4 subunit. In addition , a
specific mechanism for phosphorylation-induced R-Smad/Smad4 complex formation was
studied. Although it had been previously established that par of the mechanism through
which phosphorylation induces Smad oligomerization is through relieving MH1-domain
mediated autoinhibition of the MH2 (oligomerization) domain, it is also evident that
phosphorylatio serves to energetically drive Smad complex formation. Though
mutational and size exclusion chromatography analysis, we established that
phosphorylation induces oligomerization of the Smads by creating an electrostatic
interaction between the phosphorylated C-terminal tail of one R-Smad subunit in a Smad
trmer with a basic surface on an adjacent R-Smad or Smad4 subunit. The basic surface
is defined largely by the L3 loop, a region that had previously been implicated in R-Smad
viii
interaction with the receptor kinase. Furthermore, the Smad MH2 domain shares a
similar protein fold with the phosphoserine and phosphothreonine-binding FHA domains
from proteins like Rad53 and Chk2. Taken together, these results suggest that the Smad
MH2 domain may be a distinct phospho serine-binding domain , which utilizes a common
basic surface to bind the receptor kinase and other Smads, and takes advantage of
phosphorylation-induced allosteric changes dissociate from the receptor kinase and
oligomerize with other Smads. Finally, the strctural basis for the preferential formation
of the R-Smad/Smad4 heterotrmeric complex over the R-Smad homotrmeric complex
was explored though X-ray crystallography and isothermal titration calorimetr. Crystal
strctures of the Smad2/Smad4 and Smad3/Smad4 complexes revealed that specific
residue differences in Smad4 compared to R-Smads resulted in highly favorable
electrostatic interactions that explain the preference for the interaction with Smad4.
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CHAPTER I: INTRODUCTION
Overview of TGF -~ Signaling
The transforming growth factor-beta (TGF-P) superfamily, includes the TGF-ps
bone morphogenetic proteins (BMPs), and activins , families of secreted polypeptide
growth factors that regulate growth and development, in organisms ranging from C.
elegans to human (Kingsley 1994; Massague, 1998; Derynck and Zhang 2003).
Strcturally related by the presence of three conserved disulfide bonds , these growth
factors have essential roles in regulating cell growth, differentiation, migration, apoptosis
and homeostasis (Shi , 2001; ten Dijke et aI. , 2002). The TGF-p ligands are able to elicit
numerous biological activities, depending on the cellular context. A well-known effect of
TGF-p is its ability to induce cell cycle arrest in epithelial cells , which is linked to its role
as a tumor suppressor (Derynck and Zhang, 2003). Other specific activities of these
ligands include regulating the immune response, directing embryonic patterning,
stimulating extracellular matrix formation, and promoting wound healing (Roberts and
Sporn 1990; Moustakas et aI. , 2001). TGF-p ligands act by binding specific
transmembrane receptor kinases, activating the Smad transducer proteins , and ultimately
regulating specific transcription (Mass ague, 1998).
The Smad proteins are the primary mediators of TGF -~ signaling
The first downstream mediator of TGF-p signaling to be identified was called
Mothers Against Decapentaplegic (Mad), after being identified from a screen for genes
that enhance decapentaplegic (dpp) signaling in Drosophila (Raftery et aI. , 1995;
Sekelsky et aI. , 1995). Homologues to Mad were later discovered in C. elegans and
named Sma- , Sma- and Sma- since mutation of these genes resulted in small body
size (Savage et aI. , 1996). The subsequent identification of several vertebrate homologues
led to the classification of these proteins as Smads , a combination of C. elegans Sma and
Drosophila Mad (Derynck et aI. , 1996). The first human homologue was the tumor
suppressor DPC4 (Deleted in Pancreatic Carcinoma, locus 4), later named Smad4 (Hahn
et aI., 1996).
The eight known vertebrate Smads are between 400 and 500 amino acids in
length, and are divided into three classes according to fuction (Figue 1-1A; Derynck
and Zhang, 2003). The receptor-regulated Smads , or R-Smads , are direct substrates of
corresponding TGF-p receptor kinases. This class of Smads is highly pathway-specific
with Smads 2 and 3 exclusively involved in TGF-p and activin signaling (Zhang et aI.
1996), and Smads 1 , and 8 active only in BMP signaling (Liu et aI. , 1996; Nishimura et
aI. , 1998). The common mediator Smad (Co-Smad) subclass includes only one protein in
vertebrates , Smad4. Smad4 participates in TGF-p signaling by associating with the R-
Smads (Zhang et aI. , 1996). The third class of Smads is known as the inhibitory Smads
or I-Smads , which includes Smads 6 and 7 (Hata et aI. , 1998a; Nakao et aI. , 1997). The
Smads are structually divergent from the R-Smads and Smad4 , and these proteins
negatively regulate TGF-p signaling by preventing R-Smad phosphorylation by the
receptor kinase or inhibiting formation of an R-Smad/Smad4 complex (Hata et aI. , 1998a;
Kavsak et aI. , 2000).
Smads and Smad4 have two distinct domains of high sequence similarity (ten
Dijke et aI. , 2000; Figure 1-1). The MHI (Mad-homology I) domain of approximately
130 amino acids is located at the N-terminus. This domain has an intrinsic DNA-binding
activity in most R-Smads and Smad4 , the only exception being Smad2 , which has a
specific insertion that precludes DNA binding (Shi et aI. , 1998; Yagi et aI. , 1999). The
MHI domain is composed of four a helices , six short p strands , and five loops. DNA-
binding is accomplished through the p2 and p3 strands , which form a P hairpin structure
(Shi et aI. , 1998). In the basal, unphosphorylated state, the MHI domain ofR-Smads
inhibits the oligomerization activity of the MH2 domain through direct binding.
Phosphorylation decreases the affnity of the MHI for the MH2 domain, thereby
relieving the auto-inhibition. This domain is also able to bind some transcription factors
although at a lower level than the MH2 domain (Hata et aI. , 1997; Massague, 1998).
The MH2 domain is approximately 200 amino acids long and located at the C-
terminus of Smads. This domain is responsible for mediating the primary activities of the
Smad proteins , including interaction with the receptor kinase and DNA-binding proteins
homo- and hetero-oligomerization, and transcriptional activation (Macias-Silva et aI.
1996; Chen et aI. , 1997; Liu et aI. , 1996; Massague, 1998). The MH2 domain ofR-
Smads also contains a conserved SSXS motif at the C-terminus , the last two serines of
which are the sites of receptor phosphorylation (Abdollah et aI. , 1997; Souchelnytskyi et
aI. , 1997). Smad41acks the consensus phosphorylation sequence, and TGF-p dependent
phosphorylation of this protein has accordingly not been reported in mammals. However
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Figure 1-1. (A) The three classes of Smad proteins. Reproduced from Hata et aI.,
1998b. (B) Smad domain organization and functions. In the basal (unphosphorylated)
state, the MHI and MH2 domains inhibit each other though interaction. R-Smads MH2
domains interact with and are phosphorylated by the activated type I receptor at the C-
termnal SSXS motif. Once activated, R-Smads associate with Smad4 and DNA-binding
proteins via the MH2 domains , and the MHI domain is able to mediate DNA binding.
Reproduced from Massague, 1998.
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TGF-p induced phosphorylation of a Xenopus Smad4 isoform, Smad4p, has been shown
(Howell et aI. , 1999). Smad4 is phosphorylated at sites in the linker domain by proteins
ofthe MAP kinase pathway, although the significance of these sites is unkown
(Derynck and Zhang, 2003).
The crystal structue of the MH2 domain of Smad4 revealed that it consists of a
central p-strand sandwich with twisted antiparallel p-sheets of five and six strands each
(Shi et aI. , 1997). The p-sandwich is flanked on one end by a three-helix bundle and on
the other end by three loops and another helix, referred to as the loop-helix domain
(Figure 1-2A). The central p-strand sandwich of the MH2 domain shares a similar p
strand topology with the phosphoserine/phosphothreonine-binding forkhead-associated
(FHA) domain, as well as with the transactivation domain of the interferon regulatory
factor IRF- , indicating that this p sandwich may be a conserved motif for binding
phosphorylated serine or threonine residues (Li et aI. , 2000; Durocher et aI. , 2000; Qin et
aI. , 2003; Takahasi et aI. , 2003).
The MHI and MH2 domains are separated by a linker domain of varying length
and sequence (Figure I- I), the C-terminal47 residues of which have been shown to be
required for mediating signaling responses in Smad4 (de Caestecker et aI. , 2000). This
region also contains phosphorylation sites for Erk-family MAP kinases , mediating cross-
talk with other signaling pathways (Kretzschmar et aI. , 1997).
Propagation of the TGF-(3 signal
TGF -p signaling is initiated by binding of a specific ligand to its corresponding
type II transmembrane receptor kinase (e. , TGF-plligand and TGF-p type II receptor),
Figure 1-2. Crystal strcture of the Smad4 MH2 domain, as solved by Shi and co-
workers. (A) The Smad4 MH2 domain comprises a central p strand sandwich, capped on
one end by a thee-helix bundle (H3, H4, H5) and on the other end by a loop-helix region
(Ll, L2, L3, HI). (B) The Smad4 MH2 domain crystallzes as a trmer. Interface
residues known to be mutated in cancer are depicted in yellow. (C) Other mutations map
to the L3 loop region, which is located perpendicularly to the trmer 
interface. All figures
reproduced from Shi et aI., 1997.
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Figure 1-3. Basic mechanism ofTGF-p signaling through the Smad 
proteins. Binding
ofTGF-p ligand to its corresponding tye II receptor induces oligomerizatio
with the
tye I receptor. Constitutively active tye II phosphorylates tye I 
reqeptor at the GS
domain, activating the receptor, and creating a binding site for R-
Smads. R-Smads bind
tye I receptor with assistance from the anchorig protein SARA. Upon 
phosphorylati
by the tye I receptor, R-Smads dissociate from the receptor-
SAR complex and are able
to homo-oligomerize, but preferentially hetero-oligomerize with Smad4. (Note: The
Smad complexes are depicted as dimers only for simplicity; the 
stoichiometr of these
complexes is a central question of this thesis.) R-Smad/Smad4 complexes trans locate
into the nucleus, bind other transcription factors , and activate TGF-p specific genes.
Adapted from Massague , 1998.
leading to formation of a complex between type II and type I receptor kinases, following
which the type I receptor kinase is phosphorylated and activated by the constitutively
active type II receptor kinase (Wrana et aI. , 1994; Figure 1-3). Phosphorylation of the
type I receptor occurs at a region just inside the plasma membrane containing a
preponderance of glycine and serine residues (GS region) (Huse et aI. , 2001), creating a
binding site for the receptor-regulated Smads, or R-Smads , which are subsequently
phosphorylated by the type I receptor kinase (Macias-Silva et aI. , 1996; Kretzschmar et
aI. , 1997). The interaction is strcturally mediated by the L45 loop ofthe type I receptor
kinase and the L3 loop ofR-Smads (Feng and Derynck, 1997; Lo et aI. , 1998; Chen et aI.
1998). For certain R-Smads , the interaction with the type I receptor kinase requires the
targeting protein SARA (Tsukazaki et aI. , 1998; Hayes et aI. , 2002).
Following C-terminal phosphorylation, R-Smads dissociate from the receptor-
SARA complex and are able to form homo-oligomeric complexes. However, in the
presence of the Co-Smad, Smad4 , R-Smads preferentially interact with Smad4 to form
hetero-oligomeric complexes (Lagna et aI. , 1996). Mutations in the L3 loop of Smad4
appeared to inhibit its ability to associate with Smad2 (Shi et aI. , 1997). Thus , the L3
loop of Smads appears to mediate two key protein-protein interactions that are essential
in TGF-p signaling: the receptor-Smad interaction, as well as the Smad-Smad interaction
(Massague , 1998).
Activated R-Smad/Smad4 complexes subsequently translocate into the nucleus.
For the R-Smads Smadl and Smad3 , this translocation is mediated by a classical nuclear
localization sequence (NLS) present in the MHI domain (Xiao et aI. , 2001). Although
this sequence is conserved in all Smads , Smad2 utilizes a different method for nuclear
translocation, by directly binding components of the nuclear pore complex (Xu et aI.
2002). Smad4 is able to constantly shuttle between the nucleus and cytoplasm, due to the
presence of both the aforementioned NLS and a nuclear export signal (NES) in its linker
domain (Watanabe et aI. , 2000). The NES is thought to be masked when Smad4 is in
complex with R-Smads , allowing R-Smad/Smad4 complexes to accumulate in the
nucleus (Derynck and Zhang, 2003). Once in the nucleus , Smads modulate transcription
through several mechanisms. Smad3 and Smad4 have direct but low-affinity DNA
binding activity to consensus Smad-binding elements (SBEs) (Zawel et aI. , 1998),
therefore Smad proteins typically interact with other DNA-binding factors such as F AST-
1 (Chen et aI. , 1996), TFE3 (Hua et aI. , 1998) and the p300 and P/CAF families
(Jankecht et aI. , 1998; Itoh et aI. , 2000). The transactivation functions of Smads are
conducted through the MH2 domain (Moustakas et aI. , 2001), but the interaction of
Smad4 with the p300/CBP co-activators requires approximately 40 amino acids of the
linker domain known as the Smad-activation domain, or SAD (de Caestecker et aI.
2000a)
TGF -~ and Smads in human disease
As with other signal transduction pathways , aberrant TGF-p signaling can lead to
a number of diseases , most notably cancer. Disease-related mutations have been
identified at every level of TGF-p signaling, including the TGF-p ligands, type I and II
receptor kinases , cytoplasmic and nuclear co-factors , and the Smad proteins (Miyazono,
et aI. , 2001). Deregulation of TGF-p signaling has been implicated in autoimmune
disorders , fibrosis , and vascular diseases such as atherosclerosis , but the majority of
pathogenic mutations within the TGF-p signaling pathway have been identified in the
context of human cancers (Dennler et aI. , 2002). The typical response of epithelial cells
to TGF-p is growth inhibition , and when this response is lost due to somatic mutations in
components of the TGF-p signaling pathway, unregulated cell growth and consequent
tumor formation can result (Derynck et aI. , 2001).
Mutations in the Smad proteins have been found in many cancers (Hata et aI.
1998b). As mentioned previously, Smad4 was originally identified as a possible tumor
suppressor gene on chromosome 18q21 , which is frequently deleted or otherwise mutated
in pancreatic carcinomas , and was therefore originally named DPC4 (deleted in
pancreatic carcinoma locus 4) (Hahn et aI. , 1996). Mutations in Smad4 are associated
with approximately 50% of pancreatic cancers and 30% of colorectal cancers (Cohen
2002; Takagi et aI. , 1996; Thiagalingam et aI. , 1996). Smad4 has also been found to be
the target of inactivating mutations , albeit less frequently, in breast (Xie et aI. , 2002),
ovarian (Schutte et aI. , 1996), lung (Uchida et aI. , 1996), prostate (MacGrogan et aI.
1997), and skin cancers (Kim et aI. , 1996; Xie et aI. , 2003). Smad2 is also coded by a
gene located on chromosome 18q21 , and has likewise been found to be mutated in
colorectal cancer (Eppert et aI. , 1996). Smad3 , despite having an overall 92% sequence
homology with Smad2 , has not been found to be mutated in human cancer (Massague et
aI. , 2000). This contrasts with the finding that Smad3-null mice become moribund with
colorectal tumors (Zhu et aI. , 1998). Other results have shown that several pathogenic
mechanisms utilizing TGF-p signaling require Smad3 (Roberts et aI. , 2003), leading to
m.o:
the proposal that while Smad2 and Smad4 may have tumor suppressive functions , Smad3
is likely a mediator of oncogenic TGF-p signaling (de Caestecker et aI. , 2000).
Inactivation of Smad2 and Smad4 can occur through gene deletion or frameshift
nonsense , or missense mutations. Study of missense mutations in Smads have been
particularly fruitful in yielding information about the mechanism of Smad-dependent
signaling (Shi et aI. , 1997; Hata et aI. , 1998b). The majority oftumor-derived missense
mutations in Smads map to the MH2 (oligomerization) domain , with only a small number
mapping to the MHI (DNA-binding) domain (Figure 1- , Massague et aI. , 2000). The
most significant tumor-derived MHI domain mutation is the mutation of a conserved
arginine , Smad2 (RI33C) in colon carcinoma and the equivalent Smad4 (RlOOT) in
pancreatic carcinoma (Eppert et aI. , 1996; Schutte et aI. , 1996). These mutations increase
the affinity of the MH 1 domain for the MH2 domain by 18 to 22- fold , possibly locking
the MH2 domain in an inhibited state (Hata et aI. , 1997). Mutation of this arginine also
causes an increase in the ubiquitin-mediated degradation of Smad2 or Smad4 (Xu and
Attisano , 2000).
Smad complex stoichiometry and mechanism of formation
The solution of the crystal structure of the MH2 domain of Smad4 provided some
of the first insights into the mechanism of formation of the active Smad complex (Shi et
aI. , 1997). As mentioned , an overwhelming majority of tumor-derived missense
mutations are found in the MH2 domain , suggesting that the loss of the functions of this
domain are somehow tumorigenic (Hata et aI. , 1998b). The Smad4 MH2 domain was
found to crystallize as a trimer (Figure I- IB). Each subunit of the trimer consists of a
iik
central p strand sandwich, flanked on one end by three helices (three-helix bundle region)
and on the other end by three loops and another helix (loop-helix region) (Figure l- IA).
In the overall structure , each interface of the trimer is defined by a three-helix bundle of
one subunit contacting the loop-helix region of an adjacent subunit. Tumor-derived
missense mutations map to three general areas in the MH2 domain. A small number of
mutations map to the central p-strand sandwich (L440R and P445H in Smad2; R441P in
Smad4) (Shi et aI. , 1997), and mutations in this region would be expected to disturb
protein folding (Hata et aI. , 1998b). This was supported by results that showed that some
of these proteins containing p sandwich mutations could not be expressed (Eppert et aI.
1996).
The majority of tumor-derived mutations in the Smad4 MH2 domain map to the
regions mediating interface contact in the crystallographic Smad4 homo trimer. These
mutations are found either in the loop-helix region (D351H , R361C , and V370D in
Smad4) or in the three-helix bundle region (D450E in Smad2; D493H in Smad4) (Hata et
aI. , 1998b) (Figure 1-3B). It was proposed that trimerization is an essential mechanism in
Smad-dependent signaling, and that the presence of mutations at the trimer interface
would disrupt signaling. Consistent with this prediction, size exclusion chromatography
of purified Smad4 revealed that wild-type Smad4 eluted as a trimer, while several of the
tumor-derived Smad4 point mutants eluted as monomers (Shi et aI. , 1997). A third group
of MH2 domain missense mutations map to the L3 loop region (Figure 1-3C). Mutations
in the L3 loop have been primarly found as null or developmental defects in 
Drosophila
Mad or C. elegans Sma , although mutation of a conserved L3 loop arginine in Smad2
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Figure 1-4. Smad mutations found in cancer. Smad4 is mutated or deleted in
approximately 50% of pancreatic carcinomas. Both Smad4 and Smad2 have also been
found to be mutated in other cancer types. The majority of tumor-derived mutations map
to the MH2 domain. Reproduced from Hata et aI., 1998b.
(R428S) has been discovered in cervical cancer (Sekelsky et aI. , 1995; Savage et aI.
1996; Maliekal et aI. , 2003). In the context of the Smad4 MH2 structure , the L3 loop is
located perpendicularly to the conserved trimer interface , and thus does not appear to
participate in subunit-subunit interactions. It is especially notable that mutation of the L3
loop disrupted the interaction between Smad2 and Smad4 , but did not appear to affect
homotrimerization of Smad4 (Shi et aI. , 1997). To account for the presence of missense
mutations at both the conserved trimer interface and the L3 loop, that differentially
affected Smad homo- and heterotrimerization , it was proposed that both R-Smads and
Smad4 were each able to form homotrimers (following activation by the receptor kinase).
The R-Smad and Smad4 homotrimers then could interact via their respective L3 loops to
form heterohexamers , which as the active signaling complex , could translocate into the
nucleus and direct Smad-dependent transcription (Shi et aI. , 1997).
Another approach to determining the stoichiometry of active Smad signaling
complexes was taken by Miyazono and colleagues , who immunoprecipitated
overexpressed, epitope-tagged Smads from mammalian cells , and analyzed these
complexes through size exclusion chromatography (Kawabata et aI. , 1998). These
studies indicated that the R-Smad/Smad4 complex was a heterotrimer , although the
stoichiometric ratio of R-Smad to Smad4 was unclear. Furthermore , while R-Smads
were capable of forming homo-oligomeric complexes following phosphorylation, Smad4
appeared to be incapable of homo-oligomerization, which was contrar to the prior
findings of Shi and colleagues.
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The stoichiometry of endogenous Smad complexes in TGF-p stimulated cells was
also assessed through size exclusion chromatography (Jayaraman and Massague, 2000).
These studies showed that the size of the Smad2/Smad4 complex was most consistent
with a heterodimer. In addition, Smad4 displayed a tendency to oligomerize in TGF-
stimulated cells , contradicting the findings of Miyazono and colleagues.
Our own approach to addressing the controversial issue of Smad complex
stoichiometry was to analyze the solution behavior of purified fragments ofR-Smads and
Smad4. In these studies , described in Chapter II, we evaluated the stoichiometry ofR-
Smad homo-oligomeric and R-SmadiSmad4 hetero-oligomeric complexes by analyzing
pseudophosphorylated proteins , in which physiological phosphorylation was simulated
by mutating the sites of serine phosphorylation to acidic amino acid residues.
A specific mechanism for phosphorylation-induced activation
Another important question regarding Smad-dependent signaling is the
mechanism of phosphorylation-induced activation ofthe R-Smads. Although part ofthe
mechanism of phosphorylation-induced activation is clearly through relieving MHI
domain inhibition ofthe MH2 domain (Hata et aI. , 1997), phosphorylation is known to
act as an energetic driver of oligomerization in many proteins. For example
phosphorylation of the STAT proteins leads to dimer formation through reciprocal
interaction between phosphotyrosine residues of one subunit with the SH2 domain of the
other (Aaronson and Horvath, 2002). Moreover, the central p-sandwich ofthe MH2
domain of Smads bears a great deal of strctural similarity to the phosphoserine and
phosphothreonine-binding FHA domain of Rad53 and several other proteins (Durocher et
, 2000; Li et aI. , 2000), as well as to the lAD domain of the IRF proteins (Qin et aI.
2003; Takahasi et aI. , 2003). This suggests the possibility that Smad MH2 domain may
be a discrete phosphoserine recognition module. Chapter III describes experiments
exploring the specific mechanism of phosphorylation- induced R-Smad/Smad4 complex
formation, primarily through crystallography and mutational analysis.
Preferential formation of the R-Smad/Smad4 complex
Although R-Smads are capable of forming stable homo-oligomeric complexes
following phosphorylation, it is well established that R-Smads preferentially associate
with Smad4 to form hetero-oligomeric complexes (Lagna et aI. , 1996). The structual
basis for this preferential formation of the R-Smad/Smad4 hetero-oligomer over the R-
Smad homo-oligomer will be addressed through crystallographic and calorimetric
analysis of two R-Smad/Smad4 strctures , described in Chapter IV of this thesis.
CHAPTER II: ANALYSIS OF R-SMAD/CO-SMAD OLIGOMERIZATION
THROUGH PSEUDOPHOSPHORYLATED MUTANTS
INTRODUCTION
As discussed in the general introduction to this thesis , a better understanding of
the structural basis for TGF-p signaling through the Smad proteins is necessary.
Characterization of the stoichiometry of hetero-oligomeric Smad complexes is of primary
importance in elucidating the overall mechanism of TGF-p signaling. Mutations in the
Smad proteins are associated with a number of diseases , most notably cancer (Blobe et
aI., 2000; Derynck et aI. , 2001). Therefore it is also important to understand how the
mechanisms of Smad-dependent signaling may be subverted in diseases like cancer.
Prior to the studies described in this thesis , it was well known that phosphorylation
induces the R-Smad proteins to form homo-oligomers, and form hetero-oligomers in the
presence of Smad4 (Lagna et aI., 1996). However, the precise stoichiometry of these
oligomeric complexes had not been clearly established. The first investigation into the
stoichiometry of the Smad complexes was by Shi and coworkers , who solved the crystal
structure of the MH2 domain of Smad4 (Shi et aI. , 1997). The Smad4 MH2 crystallized
as a trimer, and coupled with mutational analysis , led the authors to propose that R-Smad
phosphorylation promotes the formation of a heterohexamer comprised of two
homotrimers: one phosphorylated R-Smad homotrimer and one Smad4 homotrimer.
Subsequent studies of overexpressed, epitope-tagged Smads in mammalian cells led to
the proposal that the activated Smad complex was a heterotrimer assembled in a manner
similar to the Smad4 homotrimer, but of which the ratio ofR-Smad to Smad4 was
unclear (Kawabata et aI. , 1998). A third model, where the R-Smad and Smad4 form a
heterodimer, was based on size exclusion chromatography of endogenous Smads in
mammalian cells (Jayaraman and Massague , 2000).
As an initial approach toward determining the stoichiometry of the heteromeric R-
Smad/Smad4 complex , we analyzed purified forms of these proteins through size
exclusion chromatography and analytical ultracentrifugation. Full-length versions of
Smad3 and Smad4 did not express well in 
E. coli therefore we used truncated forms
containing the MH2 oligomerization domain and par or all of the linker region (Figure 2-
1). Smad4AF ( tive Eragment) had previously been determined to be the minimal
Smad4 fragment capable of directing transcription (de Caestecker et aI. , 1997). The R-
Smads Smad3 (TGF-p/activin) and Smadl (BMP) were studied to identify possible
differences between the mechanisms of Smad-dependent signaling in the TGF-p/activin
and BMP signaling pathways. Smad3(LC) and Smadl(LC) contained the entire linker
and MH2 domains of Smadl and Smad3. Attempts to obtain phosphorylated forms of
S3LC and S lLC through enzymatic means or peptide ligation were not immediately
successful; therefore we attempted to mimic phosphorylation by replacing the sites of
serine phosphorylation with either glutamic acid or asparic acid residues.
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MATERIALS AND METHODS
Reagents
EDTA and NaCI were purchased from Sigma; DTT from BioRad; HEPES from
Fisher; TCEP from Pierce. All restrction enzymes were purchased from New England
Biolabs unless otherwise indicated. Oligonucleotides for PCR were purchased from
Sigma-Genosys.
Construction of expression plasmids and mutagenesis
The cDNA-derived fragments for Smad3LC (S3LC, residues 145-425), SmadlLC
(SILC , residues 143-465), and Smad4AF (S4AF, residues 273-552) were generated by
PCR using primers containing the appropriate restriction sites. S3LC and S lLC were
subcloned into the pGEX-6Pl vector and S4AF into the pGEX-4T2 vector (Amersham
Biosciences). Vectors and cDNA inserts were treated with the appropriate restriction
enzymes to generate complementary ends. Vectors were further treated with alkaline
phosphatase to prevent re-ligation of the empty plasmid. cDNA inserts were ligated into
vectors with T4 DNA ligase.
Site-directed mutants were produced through a PCR-based approach , primarly
with the QuikChange kit (Stratagene). Primers (-30-40 nucleotides long) were designed
to include the desired mutation , as well as a silent restriction site mutation that could be
used to rapidly determine the success of the PCR mutagenesis. Following a series of
PCR cycles , the original template DNA was destroyed through DpnI treatment. The
resulting DpnI- treated PCR product was used to transform competent E. coli cells (strains
HBlOl or DH5a), and transformed cells were plated on LB-agar plates containing 200
I-g/ml 
of ampicilin. Plasmids from the resulting colonies were isolated with the
QIAprep Miniprep kit (QIAGEN) and screened by restriction digest. Confirmation of the
desired mutation was obtained by DNA sequencing.
The S4AF(3E) mutant was generated through cassette mutagenesis , in which the
nine C-terminal residues of Smad4 (544-552 , PIADPQPLD) were replaced by the eleven
terminal residues of pseudo phosphorylated Smad3 (415-425 , GSPSIRCEEVE). PCR
mutagenesis was used to engineer a new silent NcoI site between codons 542 and 544.
Wild-type S4AF in the pGEX-4T2 vector was treated with Neal and EcoRI and the C-
terminus of S4AF was excised through purification and extraction from agarose gel
(QIAquick Gel Purification kit, QIAGEN). The double-stranded DNA cassette
containing the pseudophosphorylated Smad3 C-terminal sequence was inserted and
ligated into the plasmid as described above.
Protein expression and purification
S3LC, SILC, S4AF , and the mutant derivatives of these proteins were expressed
as glutathione- transferase (GST) fusion proteins in E. eoli (HBlOl strain). Cells
transformed with the appropriate plasmid were grown at room temperature in tryptone
phosphate media to an optical density (600 nm) of approximately 0. , at which point
protein production was induced by adding IPTG to a concentration of 0.05- 2 I-M. Cells
were allowed to continue growing at room temperature with constant shaking for 30-
hours. Cells were pelleted by centrifuging at 5000 rpm for 30 minutes, and resuspended
in harvesting buffer (50 mM Tris-HCl , 100 mM NaCl , 2 mM EDTA , and I/lM PMSF)
before flash freezing in liquid nitrogen and storing at - C until needed.
Cells were sonicated, then centrifuged at 15000 rpm for 45 minutes to obtain a
clarified extract. DTT was added to the extract at a concentration of 5 mM , and the
extract was combined with glutathione sepharose beads (Amersham). The extract/bead
mixture was incubated at 4 C for 3 hours , with constant stirng. Following incubation
the mixture was poured over a fritted column and the extract was eluted, and the
remaining glutathione sepharose beads were washed extensively with FPLC buffer (20
mM Tris-HCl , 100 mM NaCl , 0. 1 mM EDTA). S3LC, SILC, and the mutants derived
from these proteins were cleaved from the GST tag by adding Prescission Protease and
incubating at 12 C for approximately 24 hours. S4AF and the mutants derived from it
were cleaved with thrombin , which required a 12-hour incubation at room temperature.
The eluted proteins were purified through ion exchange chromatography, using
the anion-exchanger DEAE-sepharose. Following release from the glutathione matrix
proteins were dialyzed (overnight , 4 C) in DEAE buffer (10 mM Tris-HCl , 10 mM NaCl
1 mM EDT A). The pH of the buffer was based on the calculated isoelectric point (pI)
of the protein and was generally 7.3 for S3LC and mutants , and 8.2 for S lLC, S4AF, and
mutants. The DEAE-sepharose column was equilibrated in an identical buffer prior to
loading of the dialyzed protein onto the column. After extensive washing of the loaded
column with DEAE buffer, a 10-300 mM NaCI gradient was applied to separate the
desired protein from impurities. Protein purity was initially analyzed through SDS-
PAGE. Proteins were concentrated with an Amicon YMI0 filter , and protein
concentrations were determined by measuring the absorbance , A , at 280 nm and using the
Beer-Lambert law:
A = Ecl
where E is the molar absorption coefficient (M- l cm- l), c is the protein concentration
(M), and I is the path length. E was calculated from the amino acid sequence using the
following equation from the method described by Gil and van Hippel (Gil and von
Hippel , 1989):
E(280) = (#Trp)(5500) + (#Tyr)(1490) + (#Cys)(125)
where #Trp, #Tyr , and #Cys are the respective numbers of tryptophan , tyrosine , and
cysteine residues in the protein. Proteins were flash frozen in liquid nitrogen and stored
at -
Size exclusion chromatography
Size exclusion chromatography (SEe) was performed with the Superdex 200 HR
analytical gel filtration column on the Akta Explorer 10 FPLC system (Amersham
Biosciences). The FPLC buffer used in the size exclusion chromatography experiments
consisted of 20 mM HEPES (pH 7.4), 0. 1 mM EDT A , 100 mM N aCl , and 1 mM DTT.
Prior to loading onto the column , the protein samples were incubated in buffer containing
1 mM TCEP for at least 60 minutes at room temperature. For most of the protein
interaction experiments described herein, the final concentration per protein in solution
was approximately 50 M (-1.5 mg/ml). FPLC operation and data analysis were done
with UNICORN software. The column was calibrated with blue dextran (to determine
void volume) and molecular weight standards ovalbumin (43 kDa), albumin (67 kDa),
aldolase (158 kDa), catalase (232 kDa), and ferrtin (440 kDa). 
SEC fractions (0.5 ml)
were collected in FPLC buffer at room temperature with a flow rate of 0.7 ml/min.
Fractions were immediately mixed with Laemmli buffer and run on 12% SDS-
PAGE
gels. Proteins were visualized by Coomassie blue or silver staining. Individual bands
within the Coomassie-stained SDS-PAGE gels were quantified with the Fluor-
Multilmager and MultiAnalyst software (BioRad).
Transcriptional response assays
Transcriptional response assays were performed by Dr. Mark de Caestecker, and
compared the difference in signaling between wild-type (full-length) Smad3 or Smadl
and the pseudophosphorylated versions of each that I had created. MDA-MB 468 or
NMuMg cells were seeded to 50% confluence and transfected with SBE-Lux , pSV -p, and
full-length forms of wild-type or pseudophosphorylated Flag-Smad3 or Flag-Smadl
, and
Smad4-Myc , using Fugene-6 (Roche) or Upofectamine (Gibco). MDA-MB 468 cells are
a Smad4-null and TGF-p unresponsive cell line derived from breast carcinoma , and
NMuMg cells are mouse mammary epithelial cells that undergo epithelial to
mesenchymal transition when stimulated by TGF-p. SBE-Lux is a consensus Smad-
binding element (Jonk et aI. , 1998) linked to a luciferase reporter gene. Cells were lysed
after 36 hours , and luciferase and p-galactosidase activity determined as described in de
Caestecker et al (1997). Luciferase values were corrected for transfection efficiency with
galactosidase , expressed as the means of three independent trasnsfections.
Experiments were repeated at least twice , with similar results. Protein expression levels
were determined in parallel experiments using COS- l cells transfected with identical
proportions of FLAG-Smad3 and Smad4-Myc used in the signaling assays , and cell
lysates were immunoblotted with anti-FLAG M2 (Kodak) or anti-Myc (9ElO) antibodies.
Analytical ultracentrifugation
Sedimentation velocity and equilibrium experiments were conducted on a
Beckman Optima XLA analytical ultracentrifuge by Dr. John Correia (Correia et aI.
2001). Samples were dialyzed against sedimentation buffer comprised of20 mM HEPES
(PH 7.4), 0. 1 mM EDTA, 100 mM NaCl, and 0. 1 mM DTT. All experiments were
repeated in the presence of 2 mM TCEP to remove nonspecific aggregation.
Sedimentation velocity experiments were performed at 42000 rpm, and velocity data
analyzed with DCDT+ (Philo , 2000; Stafford, 1992). The weight average sedimentation
coeffcient values were fit to both a monomer-trimer and a monomer-dimer-trimer model
with Fitall (MTR Software , Toronto , Canada) as described (Correia, 2000). Based upon
similar size and sequence, monomers of S3LC , S3LC(3E), SILC , and SILC(2D) were
assumed to have similar s values to that of S4AF, 2.46 S20 w (2.65 Sapp
Sedimentation equilibrium experiments were performed at 28K rpm for S4AF
20K and 22K for S3LC , 20K for S3LC(3E) and SILC(2D), 16K and 20K for SILCS
22K for S lLCS(2D), and 24K for S4AF(3E). Data sets were fit with NONLIN to an
appropriate association scheme as described in detail elsewhere (Johnson et aI. , 1981).
RESUL TS
Smads and Smad4 display different oligomerization tendencies
Our approach to understanding the molecular basis for Smad oligomerization was
to analyze the behavior of the purified proteins in solution. Previous reports have shown
through yeast two-hybrid and co-immunoprecipitation analyses that the C-terminal Smad
MH2 domain is responsible for mediating both homomeric and heteromeric interactions
(Wu et aI. , 1997). Since the full-length forms of Smad3 and Smad4 formed irreversible
aggregates when expressed as GST - fusions in E. coli we used truncated proteins from
which the N-terminal MHI domain was deleted (Figure 2- 1). The S3LC constrct
contained the entire linker and MH2 domains ofSmad3 (residues 145-425). SILC
included the identical domain range (residues 143-465), however an insertion in the
linker domain made this construct slightly larger than S3LC. The S4AF constrct
contained the MH2 domain and the 45 C-terminal residues of the linker domain (referred
to as the Smad activation domain, or SAD). This constrct had previously been defined
as the minimal fragment of Smad4 required for transcriptional activity (de Cae stecker et
aI. , 1997), and its crystal structure had been previously solved in our laboratory by Dr.
Bin Qin (Qin et aI. , 1999).
Oligomerization of S3LC and S4AF was initially analyzed by size exclusion
chromatography (Figure 2-2). Both proteins were applied to the gel filtration column at 4
different concentrations (6 , 17 , and 150 M). S3LC elutes as an apparent monomer
at the lowest concentration, but displays a concentration dependent tendency toward
oligomerization, with a plateau approaching a trimer. S3LC also displayed a tendency to
MH1 Linker MH2
DNA-binding oligomerization(((((0(((((
)))))))))))((((((((((:-))))))
Smad4
Smad3
Smadl
((((((((((((:- :- :- :- :- :- :- :- :- :- :- :-
0: (. 0: 0( -: 0: -: 0( 0:" 0( 0(
.:
Smad
activation
domain
273
phosphorylation
sites
SSVS
1425
L3 loop
42,5
SSVS
1465
S3LC
L3 loop
465\ SlLC
Smad4-
specific
insertion
L3 loop
552
S4AF
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form high molecular weight aggregates, a process that was reversed by incubation of the
sample with 1 mM TCEP (data not shown). In contrast, S4AF behaves as an apparent
monomer, even at the highest concentration tested. The data appear to indicate that R-
Smads possess an intrinsic propensity for oligomerization, while Smad4 does not
, despite
considerable sequence similarity.
The size exclusion chromatography results were verified through sedimentation
analysis of the S3LC , S lLC, and S4AF constructs. (Specific experimental details of the
sedimentation experiments can be found in Correia et aI. , 2001.) Sedimentation velocity
analysis of S3LC revealed that the sedimentation coefficient patterns , or g(s), shifted to
higher values with increasing concentration, indicative of a reversible self-association
process (Figure 2-3B). A similar pattern was observed in sedimentation velocity analysis
of SILC (Figure 2- , top panel). However, as observed in the SEC experiments
described above , S3LC displayed a tendency to form high molecular oligomers during
sedimentation , which appeared to be reversible by the addition of TCEP. This reversible
self-association of S3LC was confirmed by sedimentation equilibrium analysis (Correia
et aI. , 2001). In both the presence and absence of 2 mM TCEP , the sedimentation
equilibrium data are best fit by a monomer-trimer model with a global fit producing a
trimerization constant (K ) of (3.09- 99) x 10 (Table 2- 1). Fitting to both nand K
yielded a value of n=2.96 (+ TCEP) or 2.98 (- TCEP), confirming that the trimer is the
predominant species in both fits. Including a dimer term, K , did not produce an
improvement in the fits, indicating that trimer formation is cooperatively favored over
dimer formation.
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Figure 2-2. Size exclusion chromatography elution profiles of S3LC (solid line) and
S4AF (dashed line) at four different protein concentrations (6 , 17 50, and 150 !-M). The
y-axis (mAU) plots absorption at 280 nm. The calculated subunit molecular weights for
S3LC and S4AF are 31565 and 30884 kDa, respectively.
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As expected from the SEC data , S4AF displays no shift with increasing
concentration and is consistent with a non-interacting, monomeric species in solution
(Figure 2-3A). The mean weight average sedimentation coefficient (S20, ) for S4AF as
calculated from DCDT + is 2.45 (:to.04) S (Figure 2-5). The S20,w values obtained from
DCDT + are calculated by a weighted integration covered by the entire range of
sedimentation coefficients covered by the g(s) distribution and corrected for the solvent
density and viscosity. The average molecular weight from single-species fits was 26905
(:t2197) kDa. An alternate data fitting method using the program SVEDBERG produced
similar results. Results for S4AF did not vary significantly:t2 mM TCEP. These results
were supported by sedimentation equilibrium runs (Figure 2-6), which produced global
best fits of the data consistent with a monomeric species in solution (average MW from
equilibrium runs = 30018 :t 597; expected MW = 30844).
The ability of unphosphorylated S3LC to interact with S4AF was also analyzed
by analytical ultracentrifugation by titrating S4AF into a fixed amount of S3LC. Rather
than producing a sum of the S4AF monomer zone and the S3LC interacting zone , the
boundar shifts to higher s values, indicative of the formation of a hetero-oligomer
between the two proteins (Figure 2-3C). Adding increasing amounts of S4AF causes the
associating zone to grow in area (concentration), with the peak consistent with trimer
formation. Eventually the addition of increasing S4AF leads to the emergence of a peak
near 2.65S app ' corresponding to excess monomeric S4AF unable to complex with S3LC.
This data is converted to a weight average S20,w value and plotted in Figure 2-
Comparng the S3LC (open and closed squares) against the S3LC + S4AF data (-
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Figure 2-3. Sedimentation velocity analysis of S4AF , S3LC , and mixtues of the two
Smad constructs. (A) g(s) profies from sedimentation velocity runs with S4AF; (---)
minus TCEP; (+++) plus TCEP. The apparent weight average s value of these data is
67 S , corresponding to the left vertical line , and consistent with a noninteracting
monomer. (B) g(s) profies from sedimentation velocity runs with S3LC + 2 mM TCEP.
The shift with increasing concentration is consistent with a reversible monomer-trimer
self-association with pure trimer corresponding to the right vertical line. (C) g(s) profiles
from sedimentation velocity rus with mixtues of a fixed amount of S3LC (7 M) and
increasing amounts of S4AF. The bold curve (+++) is S3LC in the absence of S4AF.
The addition of S4AF immediately causes an overall shift to higher s values. When there
is more S4AF in solution than is able to complex with S3LC , excess S4AF runs as
monomer.
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Figure 2-4. Sedimentation velocity analysis of S lLC (top panel , 6 to 49 IlM) and
SILC(2D) (bottom panel , 2 to 26 IlM) and presented as g(S ) vs. S w plots.
The data were converted to weight average S20,w values and best fit to a monomer-
dimer-trimer model. The fits are shown in the insert, where the weight average
S20,w values of SILC and SILC(2D) at different concentrations are shown by
triangles and squares , respectively. The monomer S value (dashed vertical line in
the upper panel) was determined to be 2.72 S20,w by extrapolation of the SILC
data. The trimer S value (dashed vertical line in lower panel) of 5.67 S20,w was
determined as described in Correia et aI., 2001. These values were used in the
fitting and are in agreement with results from sedimentation equilibrium
experiments (Table I). Replacing the two C-terminal serines with aspartic acid
residues results in a considerable enhancement of trimerization , as the overall
trimerization constant K3 increases from 1.11 X 10 to 2.29 X 10
pattern) appears to show that the mixed sample has a larger average size , indicating that
the heteromeric S3LC/S4AF complex is tighter (equilibrium is shifted more toward
oligomer) than the self-associating S3LC homomeric complex. It is possible that the
shape of the heteromeric complex causes the increase , but given the similar size and
sequence of the S3LC and S4AF constructs , heteromeric complex should be
hydrodynamically similar to the S3LC homomer (Qin et aI. , 1999). The reason for the
decrease in S20,w at higher protein concentrations is due to the contribution of excess S4AF
to the average molecular weight (Philo, 2000).
Phosphorylation promotes R-Smad homotrimerization
Since phosphorylation of the R-Smads results in the activation of these proteins
we sought to analyze differences in solution behavior between the phosphorylated and
unphosphorylated forms ofthe R-Smads. However, since we were initially unable to
produce phosphorylated forms of the R-Smads , we instead replaced the C-terminal
serines which are the putative sites of phosphorylation with acidic amino acid residues
either glutamic acid or aspartic acid, in an attempt to approximate phosphorylation. This
approach has been previously used by several others to mimic phosphorylation
(Thorsness and Koshland, 1987; Maciejewski et aI. , 1995; Pullen et aI. , 1995). It had
also been previously shown that replacement of the three C-terminal serines of Smad3
with aspartic acid resulted in a constitutively active Smad3 capable of mediating 
in vivo
TGF-p responses in the absence ofTGF-p stimulation (Liu et aI. , 1997; Funaba and
Mathews , 1997). Although it had been shown that the two C-terminal R-Smad serines
are phosphorylated (Abdollah et aI. , 1997; Souchelnytskyi et aI. , 1997), the complete
Construct +/- TCEP K3 (x 10 rms Method
S3LC 090 597 , 3.6911 0056 equilibrium
991 588 , 3.4821 0067 equilibrium
097 1240 S20,w (1-
1.478 :: 0.326 0117 SED FIT (1-3)b
109 1265 S20 w (1-
1.150 0437 S20 w (1-
150 0465 S20 w (1-
S3LC(3E) 54. 76 42.99, 70.901 0062 equilibrium
51.94 40. , 67.601 0058 equilibrium
74. 0686 S20,w (1-
92. 0519 S20 w (1-
36. 0908 S20,w (1-
52. 0356 S20 w (1-
Table 2-1. Trimerization constants for S3LC and S3LC(3E) as determined through
either sedimentation equilibrium or sedimentation velocity (S20,
) methods. arms
deviation of the fit; in units of OD for equilibrium and SEDFIT analysis; in units of 
for weight average fitting. bAverage values (10 data sets with S3LC - TCEP) from
single-experiment fits to a monomer-trimer model.
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Figure 2-5. Weight average S20,w values derived from g(s) analysis of sedimentation
velocity runs with S4AF (open and closed circles), S4AF(3E) (closed diamonds), S3LC
(open and closed squares), and S3LC(3E) (open and closed triangles). The closed
symbols represent data collected in the presence of 2 mM TCEP. S3LC and S3LC(3E)
data were best fit to either a monomer-trimer (dotted line) or a cooperative monomer-
dimer-trimer model (dashed line) (see Table 2- 1). Experiments performed using mixtures
of S4AF + S3LC (-x-x-x) or S4AF + S3LC(3E) (- +) contained TCEP. The initial
addition of S4AF to S3LC or S3LC(3E) causes a shift to more trimer and a larger S
value , indicating that the heterotrimeric interaction is tighter than the homotrimeric
interaction.
1.4
.; 0,
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Figure 2- 6. Sedimentation equilibrium runs of S4AF (28 K, 24. C, no TCEP). Loading
concentrations were 2 , 4 , 6 8, 10 , and 12 M. (A) Equilibrium data and best fits. (B)
Distribution of residuals. The best global fit of the data (2 runs) is consistent with 
monomeric species in solution giving a measured molecular weight of 30018 :! 597
(expected MW = 30844), with an average rms deviation of 0.00414. Experiments in the
presence of TCEP at lower speeds are also consistent with S4AF behaving as a monomer
in solution.
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conservation of all three serines of the SSXS motif among the R-Smads suggested the
possibility that all three serines could be phosphorylated. Also , given that glutamic acid
is less charged than phospho serine, mutating all three serines to glutamic acid might more
accurately approximate the charge of the physiologically phosphorylated R-Smad C-
il!
terminus , even if only two serines are actually phosphorylated. Therefore, we created
two versions of pseudophosphorylated S3LC. S3LC(2E) has the last two serines
substituted with glutamic acid, S3LC(3E) has all three serines substituted. (Subsequent
studies have shown that phosphorylation of the N-terminal-most ofthe three serines is
energetically destabilizing.) Both the 2E and 3E versions of S3LC behaved similarly in
cell signaling assays and in in vitro 
biochemical analyses. However, most ofthe S3LC
analyses were performed with S3LC(3E), which was more resistant to time-dependent
aggregation than S3LC(2E), although we found that the addition of TCEP helped prevent
aggregation of these proteins. A pseudophosphorylated form of Smadl was also created
SILC(2D), in which the C-terminal serine phosphorylation sites were mutated to aspartic
acid residues.
To verify that the pseudophosphorylated R-Smads were suitable mimics of actual
phosphorylation, signaling assays were performed to analyze the ability of the
pseudophosphorylated mutants to drive Smad-dependent transcription from a consensus
Smad binding element. As shown in Figure 2-7 A, full-length Smad3(3E) was able to
drive transcription with approximately three times the activity of its unphosphorylated
counterpart. Smadl(2D) also displayed a similar ability to activate transcription over
wild-type protein(Figure 2-7B), confirming that these pseudophosphorylated mutants are
indeed a suitable mimic of phosphorylatio
We further analyzed the solution behavior ofthe pseudophosphorylated mutants
through size exclusion chromatography. S3LC(3E) eluted as a larger molecular weight
species than the wild type protein (Figue 2-8), indicative of oligomerization. An
identical result was observed with SILC(2D) and wild-type SILC (Figure 2- 15B
, top
panels). These results confirm that the pseudophosphorylated R-Smads effectively
mimic the homo-oligomerization ability ofthe phosphorylated proteins.
The SEC results were again verified by sedimentation experiments.
Sedimentation velocity data for S3LC(3E) in the presence of TCEP is shown in Figue 2-
9A. The g(s) patterns shift to higher values with increasing concentration, indicative of a
reversible self-association. The curves are shifted more to trimer formation than the
S3LC data (compare Figure 2-3B). The data (:t TCEP) were again converted to S20
values and fit to a monomer-trimer and a cooperative monomer-dimer-
trimer model
(Table 2- 1), and best fits are also shown in Figure 2-5. The best monomer-trimer fits
(:t TCEP) are consistent with an overall equilibrium constant of (3.63-7.43) x 10
approximately 32 to 35-fold more than the equivalent data for wild-tye S3LC (Table 2-
I). These results were verified by sedimentation equilibrium experiments (data not
shown, see Correia et aI. , 2001). The best fit is to a monomer-trimer model with K3
varying from 5. 19 x 10 10 to 5.48 x 10
10 M- (Table 2- 1). This agrees well with the weight
average data and corresponds to an approximately 17- fold enhancement of trimerization
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Figure 2-7A. The 3E mutant of Smad3 greatly increases Smad3/Smad4 dependent
transcription. NMuMg cells were transfected with a consensus Smad-binding element
linked to a luciferase reporter gene (SBE-Lux) along with full-length wild-type (WT)
Smad3 or the Smad3(3E) mutant with or with full-length WT Smad4. The basal activity
observed in the absence of Smad4 was due to the NMuMg cells expressing endogenous
Smad2/3 and Smad4, as determined through Western blot (data not shown).
Control
WT Smad1
Smad1(2D)
Smad4 +Smad4
Flag
Myc
Flag-Smad1
Smad4-Myc
- WT 20 - WT 20
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Figure 2-7B. The 2D mutation greatly increases SmadllSmad4-
dependent transcription. NMuMg cells were transfected with SBE-
Lux along with full-length wild-type (WT) Smadl or the Smadl(2D)
mutant, in the presence or absence of full-length WT Smad4. Both
the Smadl and Smad4 constructs had similar expression levels.
(Bottom) Lysates from NMuMg cells transfected with Flag-tagged
Smadl and Smad4-Myc were separated by SDS-PAGE and
immunoblotted using anti-Flag M2 (Sigma) or anti-Myc 9ElO
monoclonal antibodies , as indicated.
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relative to the wild-type S3LC sedimentation equilibrium data. From the plot of SZO w vs.
protein concentration for S3LC(3E) (open and closed triangles in Figure 2-5), it can be
seen that that trimer formation is 50% complete at 3.3 to 5.2 !!M for S3LC(3E), as
opposed to 18-29. 5 !!M for wild-type S3LC (Figure 2- , open and closed squares).
Therefore pseudophosphorylated S3LC(3E) displays a 17 to 35-fold greater tendency to
homotrimerize over unphosphorylated S3LC.
The Smadl constructs S lLC and S lLC(2D) were also examined by sedimentation
analysis. These constructs behaved identically to S3LC and S3LC(3E), with the
pseudophosphorylated SILC(2D) displaying a 200-fold greater tendency to
homotrimerize over SILC (Figure 2-4 (bottom); Table 2-2). A smaller fragment of
Smadl , SILCS , and its pseudophosphorylated mutant SILCS(2D) were also studied.
S lLCS consists ofresidues 217 to 465 of Smadl , compared to 143 to 465 for S lLC.
From sedimentation velocity results, SILCS(2D) displayed an approximately 4000-fold
greater ability to homotrimerize vs. S lLCS (Table 2-2). This result suggests that the 
terminal part of the linker domain may have a role in inhibiting R-Smad trimerization, as
has been suggested previously (Hata et aI. , 1998). These results were also supported by
sedimentation equilibrium studies.
Attachment of a pseudophosphorylated tail to Smad4
Despite high sequence homology with the R-Smads (Figure 2- 14), Smad4 clearly
lacks the ability to homo-oligomerize. Since the most apparent strctural difference
between Smad4 and the R-Smads is the presence of the C-terminal phosphorylation
sequence in R-Smads , we examined whether the lack of the phosphorylation site could
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Figure 2- 8. Size exclusion chromatography elution profiles of S3LC and S3LC(3E),
loaded at 50 ""M each. The y-axis (mAU) plots absorption at 280 nm. Coomassie-
stained SDS-PAGE gels of the eluted fractions are shown.
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Figure 9. Sedimentation velocity analysis of S3LC(3E) and mixtures of S4AF and
S3LC(3E). (A) g(s) patterns from S3LC(3E) in the presence of TCEP. (B) g(s) patterns
from a fixed amount of S3LC(3E) (+++ , 7 f.M) and increasing amounts of S4AF. The
S20 w values of the data in these panels are plotted in 
Figure 2-5. Similar results were
obtained in the absence of TCEP.
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Construct 11 K3 
SILC 322
300 1.11
SILC(2D) 25. 152
20. 229
S I LCS 481 0.43
470 0.45
S lLCS(2D) 6.4 2410
2140
Table 2-2. Summary of analytical ultracentrifuge
association. aRepresents the midpoint of the trim
concentration. K3 is the overall trimerization can
the fit; in units of OD for equilibrium; in units a
velocity data. cln all other cases , a 1- 3 model b
equilibrium experiments with S lLC and S lLCS
extent of association in these two cases is only ap
accurate determination ofK3 from a 1- 3 model
Method
0093 equilibrium
0049 velocity
065 equilibrium
242 velocity
068 equilibrium
081 velocity
077 equilibrium
321 velocity
studies on Smadl homomeric
erization reaction in units of protein
stant. bRoot mean square deviation of
S for weight average fitting of
est fits the data; however, for
a 1-3 model best fits the data. The
proximately 10% , thus making an
difficult.
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solely explain the inability of Smad4 to homotrimerize , in contrast to the R-
Smads. To
address this question, we engineered a mutant form of S4AF in which the 9 C-
terminal
residues were replaced by the 11 C-terminal residues of S3LC(3E). This
pseudophosphorylated" Smad4 was designated S4AF(3E). Size exclusion
'II
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chromatography revealed that this protein was monomeric in the presence of TCEP
, but
displayed an increased tendency toward nonspecific aggregation in the absence of TCEP
(data not shown). This result was verified by sedimentation analysis. In the presence of
TCEP , sedimentation velocity and equilibrium data were consistent with a homogeneous
monomer, resulting in a weight average value of2.
7S (the closed diamonds in Figure 2-
5 and the left vertical line in Figure 2- 10; Correia et aI. , 2001). Therefore it appears that
the phosphorylated tail is not suffcient for mediating Smad homo-oligomerization
, and
that other strctural differences between R-Smads and Smad4 must be present that allow
Smads to homotrimerize upon phosphorylation. One such difference could be the
unique insertion found between helix 3 and helix 4 of Smad4 , which is not present in R-
Smads. Along with the lack of a C-terminal phosphorylated tail, this Smad4-specific
insertion might preclude Smad4 homonier formation.
Stoichiometry of the R-Smad/Smad4 heteromeric complex
The stoichiometr of the activated R-Smad/Smad4 complex that translocates into
the nucleus and activates transcription of Smad-specific genes is unclear. 
As stated in the
introduction, it has been suggested that this complex is a heterohexamer (Shi et aI. , 1997),
a heterotrimer (Kawabata et aI. , 1998), or a heterodimer (Jayaraman and Massague
2000). Our approach to this question was to analyze complexes of pseudophosphorylated
0.4
A. 0.
0.2
A. 0.
V 0.
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Figure 2- 10. (A) Sedimentation velocity g(s) data for S4AF(3E) at 42K , 24. C, in the
absence (solid lines) and presence (+++) of 2 mM TCEP. The average sapp values are
04 and 2.70 S , respectively, as indicated by the two vertical lines. These data are
consistent with a mixture of monomers and cross-linked dimers in the absence of TCEP
and homogeneous monomers in the presence of TCEP. The S20 w values of the + TCEP
data are plotted in Figure 2-5. (B) An example of a two-species Gaussian fit (solid line)
performed with DCDT + demonstrating the quality of the fit with a monomer and a cross-
linked dimer. The two species are represented by the dotted lines, while the actual data
(every 5 point) are plotted as open circles.
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Smads with Smad4 through size exclusion chromatography and analytical
ultracentrifugation. The interaction of S3LC(3E) and S I LC(2D) with Smad4 were both
analyzed in this manner. S4AF directly interacts with S3LC(3E) as evidenced by the co-
elution of these proteins on the SEC (Figure 2- 11A). When mixed at a I: I mole ratio
part of the S4AF protein co-elutes in the same fractions as S3LC(3E). However, a
significant amount of S4AF remains uncomplexed and elutes as monomer on the SEC
indicating that the heteromeric Smad complex is not a I to I dimer. The position of the
elution peak ofthe S3LC(3E)/S4AF complex is coincident with that ofthe homotrmeric
S3LC(3E), suggesting that this heteromeric complex is a trimer as well. Furhermore, the
height and position of the heteromeric elution peak remained unchanged when either a
four-fold more or three-fold less S4AF was combined with S3LC(3E) (Figure 2- 11A , 4
and 5 panels), an indication that Smad3 is the limiting reagent in heteromeric complex
formation. In addition, we determined through densitometry of the bands in the
Coomassie-stained gels that the amount of S3LC(3E) in the fractions containing complex
was almost exactly twice the amount of S4AF , regardless of the amount of S4AF in
III
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solution. A similar analysis was applied to the S 1 LC(2D)/S4AF complex, which
produced identical results to the S3LC(3E)/S4AF analysis , indicating a conserved
mechanism for all R-Smads (Figure 2- 11B). These data strongly suggest that the R-
Smad/Smad4 heteromeric complex is a heterotrimer with preferred stoichiometry of two
subunits of phosphorylated R-Smad, and one subunit of Smad4. This 2: 1 stoichiometry of
the heteromeric Smad complex was confired through sedimentation velocity analysis.
Ii:;
I!,
Figure 2-9B shows the g(s) patterns for mixtures of fixed amounts of S3LC(3E) with
increasing amounts of S4AF , and the same experiment repeated with S lLCS(2D) and
S4AF is shown in Figure 2- 12. As in the equivalent S3LC experiment (Figure 2-3C), the
addition of S4AF does not produce a sum of g(s) patterns , but instead causes a shift to a
larger extent of association. The boundary, represented by the g(s ), shifts to a faster
sedimenting form that with increasing addition of S4AF approaches the sedimentation
coefficient oftrimer. The trimer zone grows in area (concentration) first, consistent with
heterotrimer formation , then addition of increasing amounts of S4AF eventually leads to
the emergence of the monomeric S4AF peak near 2.65 S or 2.724 S , as the ratio of S4AF
to S lLCS(2D) becomes greater than I to 2. From the plot of weight average as a
function of protein concentration (Figure 2-5), the S3LC(3E)/S4AF sample initially has a
larger average size at the same total protein concentration as S3LC(3E) alone , indicating
that the heterotrimer is a tighter complex than the homotrimer, i. , equilibrium is shifted
more toward the oligomeric state. Not surprisingly, as excess monomeric S4AF
accumulates, the weight average value decreases. The significant shift in boundar upon
addition of S4AF indicates that the formation of heterotrimer is tighter than the formation
of pseudophosphorylated homotrimer (Figure 2-9B and Figure 2- 12).
Role of the conserved trimer interface
The subunit packing arrangement in the previously solved crystal strctures of the
Smad4 MH2 domain and S4AF (Shi et aI. , 1997; Qin et aI. , 1999) appears to implicate
trimer formation as an important mechanism in Smad-dependent signaling. Although
Smad4 is monomeric in solution, the subunit packing interfaces of the crystallographic
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Figure 2-11. The R-Smad/Smad4 heteromeric complex is a trmer consisting of two R-
Smad subunits and one Smad4 subunit. Size exclusion chromatography runs of (A)
S3LC(3E) and S4AF and (B) S LC(2D) and S4AF were performed, with varing S4AF
concentrations. Eluted fractions were analyzed through SDS-PAGE. The "total" relative
mole ratio refers to the ratio of S4AF to S3LC(3E) or SILC(2D) in solution, prior to
loading on the size exclusion column. The "complex" relative mole ratio refers to the
ratio of S4AF to the respective R-Smad in the elution peak of the complex (fractions 15
and 16 for S3LC(3E) or fractions 16 and 17 for SILC(2D)), as determined from the
analysis of the Coomassie-stained bands with the Fluor-S Multilmager and MultiAnalyst
software (Bio-Rad). Standard deviations were obtained from multiple measurements of
background at different regions of the gels.
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Figure 2- 12. Sedimentation velocity analysis of SILCS(2D)/S4AF. SlLCS(2D) (X line
77 f!M) was titrated with increasing amounts of S4AF (solid lines , 2.59, 5.79, 10. 16,
15. , and 20.34 f!M). Experiment was performed at 24. C, 42000 rpm, + 2 mM TCEP
and presented as a plot of g(S 20, ) versus S* w to demonstrate the formation of
heterotrimer. The vertical dashed line corresponds to trimer (4.682 S20 )' At higher
S4AF concentrations, the excess S4AF sediments as monomer , indicated by the vertical
dotted line at 2.724 S20
trmer include highly conserved residues 
to which the majority of tumor-derived
missense mutations ofS4AF map (Figure 2- 13). The MH2 domains ofR-Smads and
Smad4 share approximately 50% homology, the major difference being the presence of a
35-amino acid insertion between helix 3 and helix 4 , found only in Smad4 (Figure 2- 14).
Based on the high sequence homology between the R-Smads and Smad4 , we
would expect these proteins to be structurally similar, and therefore expect both R-
Smad/Smad4 heterotrimerization and R-Smad homotrimerization to be mediated by a
similar crystallographic ally conserved trimer interface. To test the idea that
heterotrimerization is mediated by a conserved interface, interface residues of S4AF were
mutated to their tumorigenic counterparts and the mutants tested for their ability to
interact with S3LC(3E) or SILC(2D). S4AF(D351H) is a mutation of an aspartic acid
residue in the B3 strand of the loop-helix region, which abolishes a key intra subunit salt
bridge. S4AF(D537E) is a mutation of an aspartic acid residue in the H5 helix of the
three-helix bundle sub domain. This conservative mutation evidently causes the loss of
subunit interaction by creating unfavorable packing at the interface. Both residues are
completely conserved in all R-Smads and Smad4 , even in Drosophila and C. elegans
Smads. Using the identical size exclusion chromatography-based interaction assay
described earlier, we found that neither mutant was able to interact with S3LC(3E) or
S lLC(2D), as the S4AF mutants did not co-elute with the pseudophosphorylated proteins
(Figue 2-15). That the heteromeric Smad interaction is dependent on Asp351 and
Asp537 of Smad4 supports the idea that the R-Smad/Smad4 heterotrimeric interaction is
mediated through an interface identical to that seen in the crystal strcture of Smad4.
TOWE
Figure 2-13. Crystal strcture of S4AF showing the homotrmer in the 
asymmetrc unit
(as solved by Qin et aI., 1999). The three subunits are colored green, blue, and red. Side
chains involved in the trmer interface contacts are shown in black. Corresponding
residues in Smad3 are given in parentheses. D351 does not directly contact the
neighboring subunit, but forms par of a hydrogen bond network with R361 and D537,
which directly link the subunits. Features that wil be discussed in more detail 
in Chapter
III are the sulfate-binding sites (boxed), and the L3 loops (depicted in yellow).
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Figure 2-14. Structure-based sequence alignment of the MH2 domains of the Smad
proteins. The secondar structural motifs are shown below the alignment. Residues in
Smad4 and Smad2 known to be mutated in cancer are highlighted in yellow. 
Sites of
phosphorylation are shown in green. The residues highlighted in red coordinate
phosphorylation and wil be discussed in Chapter III. Adapted from Wu et aI., 2001b.
Iii
Ii!
!III
To test whether R-Smad homotrimerization occurs through the same Smad4
crystallographic trimer interface, we made mutations in the pseudophosphorylated R-
Smads S3LC(3E) and SILC(2D) that were equivalent to some of the tumorigenic
mutations found in Smad4 (Figure 2- 16). Of the R-Smads , only Smad2 is known to be
mutated in cancers. Although Smad3 and Smadl are not known to have any tumorigenic
mutations , it has been discovered that these proteins can mediate aberrant signaling in
cancerous cells, rather than being inactivated (de Caestecker et aI. , 2000; Roberts et aI.
2003). However, if the R-Smads homotrimerize via an interface identical to that seen in
the Smad4 crystallographic trimers, creating mutations equivalent to the tumorigenic
Smad4 mutations in R-Smads should disrupt homotrimerization.
The mutations equivalent to the tumorigenic p3 strand mutation S4AF(D351H) in
pseudophosphorylated Smad3 and Smadl are S3LC(3E , D258H) and S lLC(2D , D297H).
The mutations equivalent to the H5 helix mutation S4AF(D537E) are S3LC(3E, D408E)
and SILC(2D , D448H) (Figures 2- 13 and 2- 14). Asp 537 in Smad4 has been found to be
mutated to either Glu or His in cancers , and we made the S lLC(2D , D448H) mutation
anticipating a more pronounced effect than the more conservative Asp to Glu substitution
might produce. A third trimer interface mutation was made in both proteins , S3LC(3E
V277D) and SILC(2D , V317D), a mutation in the L2100p of the loop-helix subdomain
whose equivalent mutation in Smad4 , V370D , is also a cancer-derived interface mutation
(Figure 2-13). Assessment of homotrimerization through size exclusion chromatography
revealed that all three tumorigenic mutations made in S3LC(3E) and S lLC(2D)
prevented homotrimerization , as the mutants eluted from the sizing column as monomers
(Figure 2- 16). Absent a crystal structure, these data support the idea that R-Smad
homotrimerization is structurally identical to and occurs via the same interface as Smad4
crystallographi homotrimerization and R-Smad/Smad4 heterotrimerization.
DISCUSSION
Determining the stoichiometr of active Smad complexes is of central importance
to elucidating the mechanism of TGF -p signaling through the Smad proteins. 
Prior
analyses of Smad complex stoichiometry have yielded disparate results
, with evidence
suggesting that the active Smad complex could be either a heterodimer
, heterotrimer, or
heterohexamer (comprising homotrimers of an R-Smad and Smad4) (Jayaraman and
Massague , 2000; Kawabata et aI. , 1998; Shi et aI. , 1997). Using glutamic acid or aspartic
acid substitutions to simulate serine phosphorylatio in purified R-Smad proteins
, we
analyzed the oligomerization state of the R-Smad homo-oligomeric and R-
Smad/Smad4
hetero-oligomeric complexes. Based on the size exclusion chromatography and
analytical ultracentrifugation analysis described in this chapter, we conclude that the
active Smad signaling complex formed between R-Smads and Smad4 is a heterotrimer
consisting of two R-Smad subunits and one Smad4 subunit. Our results are in agreement
with those of Kawabata and colleagues , who determined through immunoprecipitatio
epitope-tagged Smad 2/3 and Smad4 that the R-Smad/Smad4 complex was a
heterotrimer. Although their data suggested that the ratio ofR-Smad to Smad4 in the
heteromeric complex might be variable, our data strongly indicate that the ratio is
immutably 2:1 in favor ofR-Smads (Figue 2- 11). It is also evident that although
158 k 67 k 43 k
45 k-
31 k
Fraction 12 13 14 15 16 17 18 19 20 21 22 23
158 k 67 k 43 k
.. .. ,- ._' ,',,""" ,, ."",,- ,.,,,,,""
13 14 15 16 17 18 19 20 21 22 23 24
S3LC(3E)
S4AF
S3LC(3E)
S4AF(D351 H)
S3LC(3E)
S4AF(D537E)
S1LC(2D)
S4AF
S1LC(2D)
S4AF(D351H)
S1LC(2D)
S4AF(D537E)
Figure 2- 15. Mutation of S4AF trimer interface residues disrupts interaction between
pseudophosphorylated R-Smads (LC domains) and S4AF. Either S3LC(3E) (A) or
S lLC(2D) (B) were mixed at a 1: 1 mole ratio and loaded onto the Superdex 200 size
exclusion column (50 M each). Eluted fractions were analyzed by SDS-PAGE and gels
stained with Coomassie blue.
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Figure 2- 16. Mutation of the equivalent trmer interface residues disrupts R-Smad
homotrimerization. Proteins were loaded at 50 f-M onto the size exclusion column.
Eluted fractions were analyzed through SDS-PAGE and gels stained with Coomassie
blue. (A) S3LC(3E) and derived mutants (B) S lLC(2D) and derived mutants.
phosphorylated R- Smads are able to form stable homotrimeric complexes , heterotrimeric
Wi. Smad/Smad4 complexes form preferentially in the presence of Smad4 (Figure 2- 11).
",.
The structual basis for this phenomenon will be addressed in Chapter IV.
Our results directly contradict those of Wu and colleagues , who used similar size
exclusion chromatography, analytical ultracentrifugation, and mutational analyses of the
Smad2/Smad4 interaction , and determined that this complex was a heterodimer (Wu et
al. 2001a). It should be noted that an unphosphorylated form of Smad2 was used in the
majority of their analyses , which we believe caused the difference with our results. 
appears that even in the absence of phosphorylation, R-Smad/Smad4 interaction can
occur , albeit incompletely, and that the heterodimer is the observed product of the
incomplete interaction. Our own sedimentation analysis reveals that S3LC and S4AF
associate even in the absence of phosphorylation (Figure 2-3C), and analysis of this
association by size exclusion chromatography reveals a complex containing only slightly
more Smad3 than Smad4 , which could be interpreted as a heterodimer (data not shown).
Analysis of (actual) phosphorylated forms of Smad2 and Smad3 in complex with Smad4
described in Chapter IV of this thesis , confirms the core phosphorylated R-Smad/Smad4
complex is a heterotrimer. However, the heterodimer model of interaction was also
supported by size exclusion chromatography analysis of endogenous Smad complexes in
TGF-p stimulated cells , which revealed that the Smad2/Smad4 complex was an apparent
heterodimer (Jayaraman and Massague, 2000). More recent analysis of epitope-tagged
Smad/Smad4 oligomers , revealed that the Smad2/Smad4 oligomer, when in complex
with the transcription factor Fast- l and bound to DNA , is a heterotrimer , while the
Smad3/Smad4 complex under similar conditions is a heterodimer (Inman et aI. , 2002). It
is also possible that these results reflect different oligomerization tendencies between
Smad2 and Smad3. We think that this is improbable , given that Smad2 and Smad3 are
approximately 95% identical between their respective MH2 oligomerization domains. It
is more likely that this reflects a difference between the core R-Smad/Smad4 complex
that translocates into the nucleus, and the DNA- and co-factor-bound form of the
complex that activates transcription. This possibility wil be addressed more completely
in Chapter IV.
We also determined that the structural determinants for R-Smad
homotrimerization and R -Smad/Smad4 heterotrimerization are similar to those seen in
the crystallographic Smad4 homotrimers (Shi et aI. , 1997; Qin et aI. , 1999). In the
crystallographic homotrimers , contact is mediated by the interaction of the three-helix
bundle of one subunit with the loop helix region of a neighboring subunit, and this is
emulated in Smad homotrimers and heterotrimers. Mutations equivalent to tumorigenic
mutations found in Smad4 were made in pseudophosphorylated versions of Smad3 and
Smadl , and were found to disrupt R-Smad homotrimerization as well as R-Smad/Smad4
heterotrimerization (Figures 2- 15 and 2- 16). This general pattern of trimeric Smad
interaction has subsequently been confired by crystal structures of Smadl (Chapter III;
Qin et aI., 2001), Smad2 (Wu et aI., 2001b), Smad2/Smad4 , and Smad3/Smad4 (Chapter
IV).
Although it has been previously established that C-terminal phosphorylation ofR-
Smads promotes oligomerization by relieving MHI-mediated inhibition of the MH2
domain (Hata et aI. , 1997), it is clear from our studies that phosphorylation also serves to
energetically drive Smad MH2 domains toward trimerization. The R-Smad constrcts
used in these studies lacked the auto inhibitory MHI domain, containing only the linker
and MH2 domains. Although the wild-type versions of the constructs displayed a
tendency to oligomerize in a concentration-dependent manner (Figures 2- , 2- , and 2-
4 (top D, phosphorylation greatly strengthens the ability of Smads to oligomerize (Figures
4(bottom), 2- , and 2-9; Tables 2- 1 and 2-2). The structural mechanism through which
phosphorylation effects Smad oligomerization is the subject of Chapter 
III ofthis thesis.
We also confirm the observation of Kawabata and colleagues that Smad4 does not appear
to form homo-oligomers under any condition (Kawabata et aI. , 1997), as opposed to R-
Smads. Since a primary structural difference between R-Smads and Smad4 is the
presence of the C-terminal phosphorylation sequence in R-Smads (Figures 2- 1 and 2- 14),
we addressed the possibility of whether this was a determinant for Smad4 homo-
oligomerization. Replacement of the Smad4 C-terminus with the pseudophosphorylated
form of the Smad3 C-terminus did not produce a form of Smad4 that was capable of
homo-oligomerization, indicating that other structural differences might be responsible
for the inability of Smad4 to homo-oligomerize , such as the Smad4-specific insertion
between helices 3 and 4 of the Smad4 MH2 domain (Figure 2- 14). It is possible that the
observed inability of Smad4 to form homo-oligomers might be an artifact of the construct
that was used, which lacked the N-terminal half ofthe protein (Smad4 , 273-552).
However, size exclusion chromatography analysis of full-length purified Smad4 revealed
that this protein also elutes as a monomer (unpublished observations). However, our
results again contradict analysis of endogenous and epitope-tagged Smad4 , which
revealed that Smad4 exists as a homo-oligomer, most likely a homo-trimer (Jayaraman
and Massague , 2000). This may reflect the presence of other factors bound to Smad4
causing it to run as an apparent oligomer, but additional studies will be required to clarify
the homo-oligomerization state of Smad4, if any.
CHAPTER III: SMAD TRlMERlZATION IS FACILITATED BY THE
INTERACTION BETWEEN THE POSITIVELY-
CHARGED LOOP-STRAD
POCKET AND THE C-TERMINAL PHOSPHORYLATED TAIL
INTRODUCTION
The experiments described in Chapter 2 effectively demonstrate that R-
Smads
homotrmerize upon phosphorylation, and in the presence of Smad4, preferentially form
heterotrmers consisting of 2 R-Smad subunits to 1 Smad4 subunit. However, while it is
clear that R-Smad phosphorylation induces trmerization, the specific role of
phosphorylati in effecting Smad trmerization is not completely understood. Although
previous studies have shown that phosphorylation induces the oligomerizati
activity of
the R-Smad MH2 domain by relieving MHI domain-mediated inhibition (Hata et aI.,
1997), the results described in Chapter II of this thesis clearly demonstrate that
phosphorylati also serves as an energetic drver for R-
Smad oligomerizati . The
studies in Chapter II utilzed constrcts of R-Smads from which the MHI domain had
been deleted, leaving only the linker and MH2 domains (referred to as S3LC and S lLC).
Although the LC domains demonstrated a tendency to oligomerize as a function of
concentration (Figures 2-2 and 2-3B), phosphorylati was necessar to induce
oligomerizati at physiological concentrations (Figures 2-4(bottom) and 2-
8). In
paricular, analytical ultracentrifugation analysis 
showed that pseudophosphorylation of
MHI-deleted R-Smads resulted in a substantial increase in 
trmerization constant (Tables
1 and 2-2). Therefore we sought to determine the specific mechanism for
phosphorylation-induced activation of the Smad MH2 domain. 
An initial clue toward
such a mechanism was obtained from the crystal strcture of a 
Smad4 fragment that had
been previously solved in this laboratory (Qin et al., 1999). S4AF had been crystallzed
in a solution containing lithium sulfate, and the strcture revealed that 
sulfate ions from
the crystallzatio solution were bound at specific sites throughout the protein (Figure 3-
1). This led to the idea that perhaps one or more of these positively charged pockets
might be able to bind the phosphorylated R-Smad tail in the heterotrmeric complex,
helping to facilitate R-Smad/Smad4 interaction. To test this hypothesis, we used similar
site-directed mutagenesis and SEC-based interaction assay methods as described in
Chapter II. The subsequent solution of the crystal strcture of a Smadl fragment
supported this hypothesis. In addition, the Smad MH2 domain was found to share a
similar protein fold with two other phosphopeptide-binding domains: the FHA domain of
Rad53 and the lA of IRF-3 (U et aI., 2000; Durocher et aI., 2000; Qin et aI., 2003;
Takahasi et aI., 2003), supporting the idea that the Smad MH2 is a conserved
phospho serine binding domain.
MATERILS AND METHODS
Reagents
Initial S 1 LCS crystal screens were performed using the Crystal Screen I and II
and Natrx kits (Hampton Research).
iio',,
Construction of expression plasmids and mutagenesis
Smad3LC (S3LC, residues 145-425), SmadlLC (SILC, residues 143-
465),
SmadlLCS (SILCS, residues 217-465), and Smad4AF (S4AF, residues 273-
552) were
generated as described in Chapter II. Site-directed mutagenesis was performed through a
PCR-based strategy using the QuikChange kit (Stratagene), also as described in Chapter
II.
Protein expression and purificatio
All versions of S3LC, S lLC, and S4AF described in this chapter were expressed
as GST fusions and purified as described in Chapter II.
Size exclusion chromatography
Size exclusion chromatography was used to detect protein interaction, as
described in Chapter II.
Transcriptional response assays
Transcriptional response assays were performed by Dr. Mark de Caestecker, and
are similar to those described in Chapter II. NMuMg cells were transfected with SBE-
Lux, full-length forms of wild-type or pseudophosphorylated Flag-
Smad3, and full-length
wild-type Smad4-Myc or the point mutants derived thereof.
Crystallzatio of S4AF(R515S) and SmadlLCS
Crystals ofS4AF(R515S) were obtained by the hanging drop vapor diffusion
technique. As expected, this protein crystallzed under nearly identical conditions to
wild-tye S4AF (Qin et aI. , 1999). Puified S4AF(R515S) (40 mglml) was combined
with an equal volume of reservoir solution containing 100 mM HEPES (pH 7.5), 250 mM
lithium sulfate , and 10% (v/v) PEG 4000. Crystals were transferred to a cryo-solvent
consisting of25% glycerol and 75% reservoir solution, and flash frozen in liquid
nitrogen. Diffraction data were collected at - 170 C using an R-
Axis IV image plate
system mounted on a Rigaku rotating anode generator. The data were collected at a
detector distance of 140 mm with oscilation per frame and were integrated and
reduced using DENZO and Scalepack (Otwinowski and Minor, 1997). The strctue was
solved by molecular replacement with the CNS softare package 
(Bruger et aI. , 1998),
using the previously solved S4AF strctue as a search model (Qin et aI.
, 1999). Rigid
body, positional, and simulated anealing refinements were 
also performed with CNS.
Crystals of S LCS were also obtained through the hanging drop method. 
Puified
SILCS (20 mglml) was combined with an equal volume of reservoir solution containing
50 mM MES (pH 6.0) and 6% ethanol. Freezing of crystals , data collection
, and
indexing of diffraction data was performed as described above. The S lLCS 
strctue was
also determined though molecular replacement, using S4AF as a search model.
Molecular replacement and subsequent refinements were performed with CNS. Model
building was performed with CHA (Sack, 1988). Strctue figues were prepared with
Molscript (Kraulis et aI., 1991), Raster3D (Merrtt and Bacon, 1997), and GRASP
(Nicholls et aI. , 1991).
RESUL TS
Mutational analysis of anion-binding pockets in Smad4
The previously solved crystal strctue of S4AF revealed that sulfate ions (from
the lithium sulfate used as a crystallization additive) were bound at specific sites
thoughout the protein (Figue 3- 1). Since phosphorylatio is required to activate the
Smad proteins, and given the chemical similarity between sulfate and phosphate ions
, we
asked whether one or more of these sulfate-binding sites might be serving as a binding
site for the R-Smad phosphorylated tail, thereby facilitating Smad trmerization. 
Three
positions in each subunit (subunits a, b , and c) of the S4AF trmer, named sites 1 , and
3, were found to bind sulfate ions, resulting in a total of nine sulfate binding sites (Sal
Sa2 , Sa3 , Sbl , Sb2 , Sb3, Sc1, Sc2 , Sc3). A tenth sulfate-binding site was located at the
junction of subunits B and C, and this lone site where the sulfate was coordinated by
residues from two subunits was designated site Sbc. All four unique sulfate-binding sites
are defined by the presence of arginine residues (Figue 3-2). Sulfate-binding site 1 is
located at the base of the Smad4-specific MH2 insertion, and the sulfate ion is
coordinated by the side chains of Arg445 and Gln442 of helix H3 , and Arg416 from helix
H2. None of the thee sulfate-coordinating residues are conserved in other Smads 
(Figue
14), so this site seemed unlikely to interact with the phosphorylated R-Smad C-terminal
tail. Sulfate-binding site 2 comprises Arg497 from helix H4 and Arg502 from the (310
strand. Arg497 and Arg502 are well conserved among Smad4 isoforms , except that the
equivalent to Arg502 in C. elegans 
is an alanine. Sulfate-binding site 3 is located in the
III
Iii
L3 loop, where the side chains of Lys507 and Arg515 coordinate the sulfate ion.
Sa1
Figure 3-1. F 0- F c map displaying the electron density of the sulfate ions bound at
individual sulfate-binding sites throughout the previously solved S4AF structure. The
map wasca1culated after simulated annealing refinement without including the
coordinates of the sulfate ions. The S4AF strcture is 
shown as a Ca trace, with subunits
A, B, and C colored blue, green, and red, respectively. Adapted from Qin et aI., 1999.
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Figure 3-2. The specific amino acid residues that comprise each of the four unique
sulfate binding sites, which are colored in purle. The location of the sulfate ions in the
context of the entire S4AF strcture is shown in Figure 3-
These residues are completely conserved in all Smad proteins. As mentioned in the
general introduction, the L3 loop had been previously shown to mediate R-
Smad
interaction with the receptor (La et aI. , 1998). Mutations in the L3 loop found in cancer
and developmental disorders have been shown to disrupt R-Smad/Smad4 hetero-
oligomerization, which led Shi and colleagues to suggest that the active Smad signaling
complex was a heterohexamer comprising homotrmers ofR-Smads and Smad4
interacting via their L3 loops (Hata et aI. , 1998b; Shi et aI. , 1997). The final sulfate-
binding site, Sbc, is located next to site Sc2, and is created by the side chains of Arg496
and Arg497 of subunit C , and the side chain of Arg372 and the backbone of Asn369 of
subunit B. These interactions are conserved among Smad4 isoforms and R-
Smads,
except that the equivalent to Arg496 in R-Smads is a threonine.
To test the idea that interaction of the C-terminal phosphorylated tail with one or
more of the sulfate-binding sites of Smad4 might mediate heterotrmer formation
, we
used site-directed mutagenesis to change arginine residues within each of the sulfate-
binding sites to serine, then analyzed the abilty of the mutants to interact with
pseudophosphorylated S3LC(3E) though size exclusion chromatography. The results of
this analysis are shown in Figue 3-3A. Mutation of Arg416 (site 1), Arg502 (site 2), and
Arg496 to serine seemed to have no effect on the interaction between S3LC(3E) and
S4AF. However, mutation of Arg515 of the L3 loop appeared to completely disrupt the
heterotrmeric interaction (Figue 3-3A). Lys507 of the L3 loop sulfate-binding site was
also mutated, resulting in a significant decrease in interaction between S4AF(K507S) and
S3LC(3E), but not a complete abolition as with S4AF(R515S) (data not shown). These
results support the hypothesis that interaction between phosphorylated R-
Smads and
Smad4 is faciltated by a specific electrostatic interaction between the phosphorylated 
terminus ofR-Smads with a putative anion-binding site in Smad4
, located in the L3 loop.
As the experiments in Chapter II demonstrate , R-Smad homotrimerization and R-
Smad/Smad4 heterotrmerization occur via a common interface. The high 
strctual
similarity between R-Smads and Smad4 suggest that an identical phosphorylated tail-
loop interaction may also mediate R-Smad homotrmerization. This was tested 
mutating the L3 loop arginine residue equivalent to Smad4 Arg515 in
pseudophosphorylated Smad3 to a serine residue. This mutant
, S3LC(3E, R386S) was
tested for its ability to homotrmerize through size exclusion chromatography. This
single mutation clearly prevents homotrmerization, as the mutant protein elutes as a
monomer (Figue 3-3B), fuher supporting the idea that a direct interaction between the
phosphorylated C-terminal tail and the L3 loop facilitates Smad protein interaction. This
also support a key result of the studies described in Chapter II, that R-
Smad
homotrmerization and R-Smad/Smad4 heterotrmerization share a common 
strctual
basis.
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Figure 3-3. (A) Analysis of interaction between S3LC(3E) and S4AF sulfate-
binding
site mutants. S3LC(3E) and sulfate-binding site mutants of S4AF were combined at a 1: 
ratio and loaded on the gel filtration column. The eluted fractions that contained protein
were analyzed by SDS-P AGE and the gels stained with Coomassie blue. 
(B) Mutation of
the L3100p arginine to serine (R386S) abrogates S3LC(3E) homotrmerization.
Crystallzation of S4AF(R515S)
We considered the possibility that the loss of interaction between S3LC(3E) and
S4AF(R515S) could be due to a gross conformational change caused by the mutation,
rather than the loss of a bond between the L3 loop arginine and the phosphorylated tail.
To determine whether the loss of interaction caused by the R515S mutation was due to a
conformational change, we solved the crystal strctue of S4AF(R515S). The protein
crystallzed in nearly identical conditions as the previously crystallized 
wild-tye S4AF
(Qin et aI., 1999). The superimposed Fo-Fc omit maps of the L3 loops of both 
wild-tye
S4AF and the R515S are shown in Figue 3- , and the crystallography statistics for the
strctue are given in Table 3- 1. It is apparent from the electron density that no change in
conformation exists in the L3 loop ofS4AF(R515S), indicating that the loss of interaction
between S3LC(3E) and R515S is due solely to the absence ofR515 in the L3 loop,
supporting the hypothesis that interaction between the L3 loop arginine and the
phosphorylated C-terminal tail stabilizes Smad complex formation.
Signaling assays confirm the importance of the L3 loop arginine
Given that the only sulfate-binding site mutation to cause a loss of Smad3/Smad4
interaction was S4AF(R515S), we wanted to establish a fuctional consequence for this
loss of interaction, by determining the effect of this mutation on Smad3/Smad4
dependent transcriptional activity. Signaling assays were performed as described in
Chapter II, to compare the ability of each of the sulfate-binding site mutants to activate
transcription from a consensus Smad-binding element (SBE) linked to a luciferase gene.
Figure 3-4. Stereo view ofthe F e omit map at the L3 loop of S4AF(R515S). 
The
mutant and wild-type coordinates are shown in black and gray, respectively.
Table 1. Summar of crystal analysis for S4AF(R515S).
Parameter
S4AF(R515S)
Crystal parameters and crystallographi data
Space group
Unit cell dimensions
Diffraction limit (Ay
Total reflections
Unique reflections
Completeness (%)
Intensity/Sigma
Rmerge 
(%)b
14(1 )22
a = b = 140.6, c = 193.
100- 0 (3. 11-
72845
19552
97.9 (88.
5 (2.3)
12.6 (48.5)
Refinement statistics
Protein atoms
R factor (% Y
Rfree factor (%)d
Rms deviation from ideal
Bond lengths (A)
Bond angles (0
factor rms deviation
Main chain (A
Side chain (A
5434
20.
26.
007
1.30
Values in brackets are for the highest resolution shell.
Rmerge = IIhkC.chk:;I/ Ihk
R factor = hkl IlFobs ealelI/ obs
l for all data.
R free = IlFobs ealell/ obs
l for 10% of the data not used in refinement.
As shown in Chapter Smad3(3E) is able to activate the SBE-luciferase gene only when
cotransfected with Smad4 (Figure 2-7 and Figue 3-5). Of the four arginine to serine
sulfate-binding site mutants , the L3 loop mutant R515S impacted signaling the most
causing a decrease of over 80% in transcriptional activity compared to wild-type Smad4
(Figue 3-5). The R416S (site I) and R496S (site bc) mutations resulted in an
approximately 50% decrease in signaling activity, and the R502S (site 2) mutant
decreased signaling by 20% from wild-tye Smad4. These data support the in vitro
results, confirming that Arg515 of the L3 loop is a critical determinant ofSmad3-Smad4
heterotrmerization. The R416S , R496S , and R502S mutations appear to impact
signaling as well , although less than the R515S mutation. However, since these other
mutants do not appear to affect interaction with pseudophosphorylated Smad3 (Figue 3-
3A), the reduction in signaling that is observed may involve components of the signaling
pathway other than Smad3 and Smad4. Furher studies wil be required to elucidate these
other components of Smad-dependent signaling.
The results of the previous sections provide strong evidence that the homotrmeric
Smad and heterotrimeric R-Smad/Smad4 complex formation are facilitated by an
electrostatic interaction between the phosphorylated C-terminal tail of an R-Smad subunit
with the L3 loop of the adjacent Smad subunit. As can be seen in Figue 2- , the L3
loop is not involved in intermolecular contacts in the complex but is instead located on a
solvent accessible surace of the trmer. However, mutations in the L3 loop have been
found in cancer and developmental diseases (Sekelsky et aI., 1995; Savage et aI., 1996;
Maliekal et aI., 2003), supporting a key role for this motif in Smad-dependent signaling.
Smad4 null MDA-MB468 cells with SBE-Lux
1.5
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Figure 3-5. The Smad4 (R515S) mutant only weakly activates Smad3/Smad4 dependent
transcription. MDA-MB468 cells were transfected with SBE-
Lux along with the
indicated FLAG-Smad3(3E) and Smad4-Myc mutant constrcts.
Although it had previously been shown that the L3 loop is involved in mediating
receptor interaction (La et aI., 1998), these studies clearly demonstrate that it also has a
role in mediating subunit interaction in oligomeric Smad complexes. It can be seen from
the previously solved Smad4 MH2 domain strctures (Shi et aI. , 1997; Qin et aI.
, 1997)
that the L3 loop is located near the C-terminus of the neighborig subunit within the
trmer. Comparing the Smad4 strctues with the strctue of the Smad2 MH2 domain
(solved in complex with the R-Smad anchoring protein SAR) (Wu et aI. , 2000) reveals
that the 10 C-terminal residues ofR-Smads form flexible extensions from the core 
(3-
strand sandwich. This flexibility could allow the 10 C-terminal residues of the R-
Smad
phosphorylated tail to form an extended conformation to reach the 
neighborig L3 loop.
Direct confirmation of this model was obtained from the crystal 
strctue of S 1 LCS
described in the following section.
Crystal Structure of SILCS
The strctual basis for R-Smad activation was fuher investigated through the
solution of the crystal strctue ofthe Smadl fragment S1LCS. S1LCS 
contains the C-
terminal 49 residues of the linker domain and the entire MH2 domain (residues 217 to
465). As described in Chapter II, the pseudophosphorylated mutat SILCS(2D) 
displays
an approximately 4000-fold improvement in ability to trmerize over SILCS, as
determined from sedimentation velocity experiments (Table 2-2). However, attempts to
crystallze S lLCS(2D) were unsuccessful, as this pseudophosphorylated protein only
produced clusters of small crystals unsuitable for diffraction. Under similar
crystallization conditions, unphosphorylated S lLCS produced well-ordered, single
i '
, "
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crystals, which diffracted to 2.5 A resolution (Table 3-2). The strctue was determined
through molecular replacement using the previously solved S4AF strctue as a search
model (Qin et aI. , 1999). The asymmetrc unit comprises four Smadl subunits (Figue 3-
6). Three subunits (subunits A , B , and C) pack as a trimer and are related by 3-fold
noncrystallographic symmetr (NCS), while the four (subunit D) interacts with the 3-
fold crystallographic symetr mates to form the same trmeric arrangement. This
trmeric arangement is similar to the previously solved strctues of Smad4 MH2 (Shi et
aI. , 1997) and Smad4 AF (Qin et aI. , 1999). Residues 217 to 267 of the Smadl1iner
region were disordered and therefore not visible. The tail of subunit D (residues 454 to
465) is similarly disordered, but the tails of the three NCS-related subunits are well
ordered and assume two distinct strctual arrangements (Figue 3-6 and Qin et aI.
2001). The tails of subunits A and B extend and interact with the L3 loops of adjacent
subunits C and A, respectively. However, the C-terminal tail of subunit C rotates about
Gly455 and interacts with the L3 loop of subunit D , leaving the L3 loop of subunit B
empty (Figue 3-6). The strctue reveals how phosphorylation of the two C-terminal
serines facilitates phosphorylation (Figue 3-7 A). The serine at the -1 position (Ser465)
is located near Lys418 and Arg426 of the adjacent L3 loop, two residues that are
conserved in all Smads. As described above, mutation of the equivalent residues in
Smad4 (Lys507 and Arg515) resulted in abrogation of the interaction between S3LC(3E)
and S4AF. It is evident from the strctue that phosphorylation of the -1 serine wil
introduce favorable electrostatic and hydrogen bonding interactions between the
Table 3-2. Summar of crystal analysis for S lLCS.
Parameter S 1 LCS
Crystal parameters and crystallographic data
Space group
Unit cell dimensions
Diffraction limit (Ay
Total reflections
Unique reflections
Completeness (%)
Intensity/Sigma
merge 
(%)b
a = b = 138. 1, c = 199.
2.5 (2.57-
77509
47621
96.8 (98.
10.4 (2.
5 (35.
Refinement statistics
Protein atoms
Water molecules
R factor (%t
Rfree factor (%)d
Rms deviation from ideal
Bond lengths (A)
Bond angles CO)
6187
586
23.
27.4
1.40
Values in brackets are for the highest resolution shell.
Rmerge = IIhk -chk Ihk
R factor = hk IIFobs ea1e lI/ hk IFobsl for all data.
R free = hk IIFobs ea1ell/ hkl obsl for 10% of the data not used in refinement.
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Figure 3-6. Crystal strcture of SlLCS. The four subunits in the asymmetrc unit are
shown in ribbon representation. The 3- fold non-crystallographi
symmetr axis 
perpendicular to the page and indicated by the (x). The 3-fold crystallographic axis in
indicated by the horizontal gray dashed line. Areas where a C-termnal tail is in 
contact
with an L3 loop are circled. L3 loops are depicted in black.
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Figure 3-'. (A) Surface electrostatic potential representati
of the interaction between
the L3 100p/P8 strand pocket and the C-termnal tail. The 
residues lining the tail binding
pocket are labeled in black, while the tail residues are labeled in red. 
(B) (top) Stereo
view of the L3 loop/tail interaction. The L3 loop main chain and side chain are colored
in cyan and green, respectively. The C-termnal tail is shown in pink. Gly419 is
indicated by a sphere. (bottom) Stereo view of the unbound L3 loop.
phosphoseri residue and the lysine and arginine of the L3 loop. 
The residue at the -
position of the C-terminus, Va1464, is solvent exposed, consistent with the non-
conservation of this residue in the R-Smads. Ser463, the residue in the -
3 position, is in
close proximity to Tyr424 ofthe L3 loop, and Lys373 ofthe p8 strand. The 
strcture
suggests that phosphorylation of this serine wil result in the formation of several
hydrogen bonds between the -3 phospho serine and Tyr424 and Lys373. 
The serine at the
-4 position has been demonstrated not to be phosphorylated from previous
phosphopeptid mapping studies (Abdallah et aI. , 1997; Souchelnytskyi et aI., 1997), and
that is supported by this strctue. The -4 serie points toward the solvent
, suggesting
that phosphorylation of this serine is unlikely to affect subunit interaction. This was
supported by analytical ultracentrfugation experiments performed on the eight
combinations of wild-tye serine or glutamic acid pseudophosphorylati
mutations of
the three C-terminal series at the -
, -
3, and -4 positions (SSVS , SSVE, SEVS, ESVS,
SEVE, EEVS, ESVE, and EEVE). The studies showed that pseudophosphorylati
only the -1 and -3 serines was strongly stabilzing, with the SEVS and SEVE mutations
exhibiting strong trmerization enhancement 
(L\L\G 
= -
9 to - 5 kcallmol), the ESVS
mutations exhibiting almost no enhancement 
(L\L\G 
= -
0.3 kcallmol), and the rest (SSVE,
ESVE, EEVS, EEVE) exhibiting intermediate enhancement 
(L\L\G 
= -
5 to -
kcallmol) (data not shown). Also noteworthy is that the conserved Gly419 in the 
L3 loop
is located at the bottom of phosphotail binding site, within van der Waals contact to the
3 serine (Ser463) (Figue 3-7A). Mutation of the corresponding glycine in Smad2 and
Smad4 has been implicated in developmental defects (Hata et aI. , 1998b). The 
strctue
suggests that mutation of this residue to anyting other than glycine would result in a
steric clash with the -3 serine, preventing the tail from interacting with the L3 loop. The
interaction between the phosphorylated tail and the positively charged pocket defined by
the L3 loop and the p8 strand provide additional subunit contact and hydrogen bonds
, and
may partly explain why R-Smads homotrmerize, but not Smad4. The bured surace
area between subunits is 2400 A 2 , of which 900 A 
2 is contrbuted by the final twelve C-
terminal residues.
Concerted structural changes drive Smadl activation
In the crystal strcture of SlLCS, the L3100p is found in two distinct
conformations. The L3 loops of subunits A, C, and D are bound to the C-
termnal tails of
adjacent subunits, whereas the L3100p of subunit B is unbound (Figure 3-7B).
Comparson between the two conformations in which the L3 loop is found reveals that it
undergoes significant rerouting upon binding of the C-terminal tail. The root mean
square deviation of the L3 loop main chain (residues 420 to 427) between two tail-
liganded subunits (NC, C/D, and D/A pais) is 0.33:t 0. 14 A, but is 1.77 :t 0.
14 A
between the tail-liganded subunits and the unliganded subunit B (AI, 
C/B, and D/B
pais). Most notably, Arg426, the putative -1 phospho serine binding residue, flps
toward the tail to form the phosphorserine binding pocket, with its guanido group moving
13 A. The adjacent His425 and Gln427 of the L3 loop undergo significant side chain
flpping as a result of this interaction. His425 and Asp428 have previously been shown
to mediate BMP receptor kinase specificity for Smadl, and switching these residues with
those in the equivalent position in Smad2 (Arg427 and Thr430) results in a Smadl that is
instead phosphorylated by the TGF-p receptor (La et aI., 1998). Therefore the L3100p
appears able to exist in two distinct conformations, one that enables interaction with the
GS domain of activated receptor kinase, and another that allows interaction with other
Smads by interacting with the phosphorylated tail.
Strctural comparson between the Smadl strcture and a Smad2 monomer
solved in complex with the anchor protein SARA reveals that the three-helix bundle of
trmeric Smadl undergoes a substantial shift (Qin et aI., 2001). SARA is a membrane-
anchoring protein that recruits (monomeric) Smad2 or 3 via its Smad-binding domain
(SBD) to the corresponding receptor kinase, and is thought to restrct movement of the
Smad thee-helix bundle and thus keep Smad 2 or 3 in a monomeric state (Figure 1-
Tsukazak et aI., 1998). Following phosphorylation by the receptor kinase, R-Smads
dissociate from the receptor/SARA complex and subsequently trmerize. Therefore 
appears that Smadl activation is defined by concerted, phosphorylation-induced
strctural changes, in which flpping of the L3 loop and tilting of the thee-helix bundle
result in a Smadl protein with a greatly increased tendency toward formng trmeric
Smad complexes.
Mutational analysis based on the crystal structure
The previous mutational analysis described above was based on the sulfate-
binding sites that were seen in the S4AF strctue. In those studies, only the lysine and
arginine of the L3 loop were mutated, as these were the only residues observed to directly
bind the sulfate ion. However, the strctue ofSlLCS reveals that the interaction of the
phosphorylated tail with the L3 loop involves more than just those two residues. In
addition to Lys418 and Arg426 ofthe L3 loop, which bind the phosphorylated serine at
the -1 position, Tyr424 of the L3 loop and Arg373 of the p8 strand also appear to bind
the phosphorylated serine at the -3 position. Each of these four potential phosphate-
coordinating residues was mutated in SILC(2D) to determine how the loss of the
phospho serine taiVloop-strand pocket interaction would affect 
homotrmerization. The
equivalent residues were also mutated in the Smad4 constrct 
S4AF to determine the
effect of mutation on heterotrmer formation with SILC(2D).
As demonstrated by size exclusion chromatography analysis in Chapter 
II, the
pseudophosphorylated S lLC(2D) constrct displays a tendency toward trmerization over
its unphosphorylated counterpart, SILC. Figue 3-8A shows the effect of mutation of the
putative phospho serine-binding sites on homotrmerization ofSlLC(2D). Mutation of all
four sites either reduces or prevents trimerization. The K373S
, K418S, and R426S
mutations display a marked decrease in homotrmerization. The conservative Y424F
mutation displayed only a slightly reduced homotrmerization from S lLC(2D). 
This may
be because the Y 424F mutation only leads to the loss of a sale hydrogen bond mediated
by the tyosine hydroxyl group, whereas the other mutations result in the loss of
positively charged residues that likely maintain strong electrostatic interactions with
phospho serine residues. The three equivalent mutations of the charged residues (K426S
in the 13 strand, and K507S and R515S in the L3 loop) in S4AF significantly reduced the
heterotrmeric interaction with SILC(2D) (Figue 3-8B). Taken together, these data
strongly support the model that both R-Smad homotrmerization and R-
Smad/Smad4
heterotrmerization require the interaction between the phospho serie 
residues ofthe R-
Smad C-terminus and a positively charged pocket in adjacent R-Smad or Smad4
subunits , defined by the L3 loop and p8 strand.
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Figure 3-8. Mutation of the Smad phospho serie-binding pocket disrupts both R-
Smad
homotrimerization and R-Smad/Smad4 heterotrmerization. (A) Mutation of the four
residues comprising the phospho serine-binding pocket of S lLC(2D). (B) Mutation of
three of the residues comprising the phospho serine-binding pocket of S4AF.
(f.
DISCUSSION
The studies described in this chapter reveal the strctural mechanism though
which C-termnal phosphorylation of the MH2 domain activates R-Smads. Although the
SILCS crystal structure was unphosphorylated, biochemical evidence and other
observations indicate that this strcture represents an active R-Smad conformation. The
size exclusion chromatography and sedimentation analysis described in Chapter II
showed that Smad3 and Smadl both displayed a concentration-dependent tendency
toward trmerization. It is therefore reasonable to suppose that under the high protein
concentration of crystallzation, unphosphorylated Smadl can form an active trmer.
Also, the interactions between the C-termnal tail and the L3 loop involve highly
conserved residues, consistent with the conserved phosphorylati mechanism of R-
Smads. This was verified by the mutagenesis experiments shown in Figure 3-
8, the
locations of which were derived from the crystal strcture. The strcture also 
explains
the occurence of tumorigenic and developmental mutations in the L3 loop, and the
critical role of the L3 loop in Smad homomeric and heteromeric interaction. This 
work
reveals that the activation mechanism employs specific docking of the phosphorylated C-
termnal SVS sequence to the L3 loop phospho serine binding pocket of the neighboring
Smad molecule to tighten a trmeric scaffold (Figure 3- 10). The trmerization event
induces concerted structural changes in the MH2 domain, which function as an allosteric
switch in signaling. The phosphoserine binding pocket and the trmer interface 
are
conserved among all R-Smad proteins, suggesting a conserved strctural mechanism.
The Smad MH2 is structurally related to other phosphoserine binding domains
The Smad MH2 domain consists of a central p-sandwich with twisted antiparalle1
p-sheets of five and six strands each (Figure 1-2A; Shi et al., 1997; Qin et aI., 1999). A
strkingly similar p-sandwich protein fold is seen in two other protein domains that have
putative phosphoserine or phosphotheonine binding activity, the forkhead-associated
domain (FHA), found in Rad53, Chk2, and numerous other proteins (Li et al., 2000;
Durocher et aI., 2000; Li et aI., 2002), and the IRF-association domain (lA) of the
interferon regulatory factors (IRs) (Erushkn and Mushegian, 1999; Qin et aI., 2003;
Takahasi et aI., 2003) (Figure 3-9). The positively charged phosphoserine or
phosphothreonine-binding surace (defined by the L3 loop and p8 strand in the Smad
MH2 domain) is conserved between the MH2, FHA and lAD domains, despite low
sequence homology (Qin et aI., 2003). Other studies have shown that the same
positively-charged surace of the MH2 domain of R-Smads binds the L45 loop and
phosphorylated GS domain of the activated TGF-p type II receptor, with receptor-Smad
specificity determed by the L45-L3 loop interaction (Huse et aI., 2001; La et aI., 1998).
Therefore the Smad MH2 domain, though a basic surface defined largely by the L3 loop,
appears to be a protein-protein interaction module capable of performng two distinct
phospho serine binding functions in TGF-p signaling, 1) binding to phosphorylated TGF-
13 type I receptor and 2) binding of phosphorylated C-termnal tails of adjacent subunits in
Smad trmers (Huse et aI., 2001; Qin et aI., 2002).
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Figure 3-9. The Smad MH2 domain is strcturally homologous to the FHA and lAD
domains. (A) (left) Superimposed p-sandwiches of the Smad2 MH2 (yellow) and Rad53
FHA (red). (right) Secondar structure topology diagrams of the MH2 and FHA
domains. Reproduced from Durocher et aI., 2000. (B) Secondar strcture topology of
Smad MH2 (left) and lAD from IRF-3 (right). Reproduced from Qin et aI., 2003.
A phosphorylation-induced allosteric switch drives Smad dissociation from the
receptor complex
Prior studies have shown that two distinct strctual mechanisms direct the
specific phosphorylati ofR-Smads by receptor kinase complexes. First
, the L45 loop
ofthe TGF-p receptor kinase domain specifically interacts with the L3 loop of an R-
Smad protein (Feng and Derynck, 1997; Chen et aI. , 1998; La et aI. , 1998; Persson et aI.
1998). Second, the receptor-associated recruiting molecule, such as SAR in 
the TGF-
p/activin pathway, specifically recruits an R-Smad protein to the receptor kinase for
phosphorylati (Tsukazak et aI., 1998). Although these mechanisms ultimately lead to
specific phosphorylation of the R-Smads, how the recruited R-
Smads disengage the
receptor kinase/recruiting molecule complex after phosphorylatio
is unown. The
strctue of the Smadl homotrmer, in comparison with other R-Smad strctues,
provides insight into how this might occur (Figue 3-10). The strctue of the trmeric
Smadl reveals that the L3 loop and the three-helix bundle strctue undergo concerted
conformational changes upon activation, which may induce Smadl dissociation from the
receptor kinase complex. In the basal state, in which Smadl is monomeric
, the L3 loop
of Smad 1 interacts with the L45 loop of the receptor kinase. In addition, the basic
surace defined by the L3 loop and the 138 strand concurently interacts with the
phosphorylated GS domain of the receptor kinase (Huse et aI. , 2001). Phosphorylation-
induced activation ofR-Smads effects two distinct strctual changes: a 
shift in the three-
helix bundle and a flpping of the L3 loop (Figue 3-7B). This results in formation of a
trmer, in which the L3 loop of an R-Smad interacts with the phosphorylated C-
terminal
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Figure 3-10. An allosteric model for Smad activation. In the basal, unphosphorylated
state, the R-Smad is a monomer. Following activation of the receptor kinase through
ligand binding, the R-Smad is recruited to the receptor kinase. The R-
Smad interacts
with the phosphoserine binding site and L45 loop of the receptor through the basic pocket
defined by the L3 loop and p8 strand. After phosphorylatio ofthe R-
Smad by the
receptor kinase, the R-Smad dissociates and is capable of forming homotrmers
, but
preferentially form heterotrmers in the presence of Smad4.
tail of another R-Smad molecule. Thus, by employing distinct conformations to interact
in a mutually exclusive manner with multiple signaling parers, the L3 loop can serve as
a switch for R-Smad dissociation from the receptor. Consistent with this model
, the
interaction between the receptor kinase complex and R-Smad is stronger when either the
terminal phosphorylation sites of the R-Smad are mutated or when kinase activity is
rendered inactive by a catalytic site mutation (La et aI., 1998; Macias-Silva et aI. , 1996).
Furhermore, the trmerization-induced tilting of the three-helix bundle strctue toward
the subunit interface may also serve as a conformational switch to direct R-Smad
dissociation from the receptor complex (Figue 3-10). In the analogous TGF-p/activin
pathway, SAR recruits and stabilizes the monomeric form of Smad2 or Smad 3.
Strctual comparison between the trmeric Smadl strctue and the Smad2/SAR 1: 1
complex strctue reveals that SAR inhibits Smad2 trmerization by restrcting
movement of the three-helix bundle, without which Smad trmerization canot occur (Qin
et aI., 2002; Tsukazaki et aI. , 1998). That the thee-helix bundle exists in different
conformations between monomeric and trmeric Smads was confirmed by the 
strctue of
an unliganded form of Smad3 (Qin et aI. , 2002). As was expected, the thee-helix bundle
of that monomeric protein was found in an identical conformation as the SARA-
bound
forms of Smad2 and Smad3 (Tsukazak et aI., 1998), whereas the thee-helix bundles of
trmeric Smadl and Smad2 display a substantial shifting (Qin et aI., 2001; Wu et aI.,
2001b). We suggest that phosphorylation energetically favors trmerization, and that
formation of trmers is sterically incompatible with receptor/SAR association. Similar
mechanisms may exist for Smadl though other as yet undiscovered receptor-associated
molecules.
CHAPTER IV: CRYSTALLOGRAPHIC AND CALORIMETRIC ANALYSIS OF
THE R-SMA/SMAD4 COMPLEX
INTRODUCTION
The studies described to this point indicate that formation of the R-
Smad/Smad4
heterotrmer is energetically preferred over R-Smad homotrmerization, and that
heterotrmer formation occurs through an 
interface identical to that seen in the
crystallographic homotrmers of Smad4 (Shi et aI., 1997; Qin et aI., 1999), Smadl (Qin et
al, 2001), and Smad2 (Wu et aI., 2001b). Contrar to our results, however, data from
other studies appears to show that the heteromeric R-Smad/Smad4 complex is a
heterodimer, rather than a heterotrmer. Size exclusion chromatography analysis of
endogenous Smad2/Smad4 complexes from TGF -p-stimulated cells revealed that these
complexes were heterodimers (Jayaraman et aI. , 2000). Smad2 and Smad3 were also
discovered to have very different endogenous homo-oligomerizatio
states , but the
oligomerizatio state of the Smad3/Smad4 complex was not determined in that study.
Subsequent biochemical analysis of the MH2 domains of Smad2 and Smad4 also
appeared to support a heterodimeric model (Wu et aI. , 200la). Additional 
mutational
analysis showed that some mutations in the putative 
heterotrmeric interfaces of Smad2
and Smad4 did not abolish interaction between those two proteins
, which would support
the notion that the Smad2/Smad4 hetero-oligomer is not mediated by the crystallographic
trmer interface (Wu et aI., 2001b). While these studies may suggest a 
fudamental
difference between the Smad3/Smad4 (heterotrmer) and Smad2/Smad4 (heterodimer)
IJ" complexes , analysis of nuclear extracts of cells transiently co-transfected with
differentially-tagged Smads revealed the opposite. Smad2 and Smad4 formed a
heterotrmer when bound to the cofactors Fast- l or Fast-3 and DNA, while the DNA-
bound Smad3/Smad4 complex was a heterodimer (Inman et aI. , 2002).
In addition to the issue of subunit stoichiometr, the mechanism ofR-
Smad/Smad4 complex formation is similarly unclear. As the experiments detailed in
Chapter II have shown, R-Smad phosphorylatio results in homotrmerization
, in the
absence ofSmad4 (Kawabata et aI. , 1998; Chacko et aI. , 2001; Qin et aI. , 2001; Wu et aI.
2001 b). The R-Smad homotrmer is strongly stabilized by the interaction between
phosphoserine residues of the C-terminal tail and positively charged residues in the L3
100p/P8 strand of an adjacent subunit, and through extensive hydrogen bonds and van der
Waals contacts at the trmer interface, as described in Chapter III and elsewhere (Qin et
aI. , 2001; Wu et aI. , 2001b). However, when Smad4 is present, the R-Smad/Smad4
heteromer clearly forms preferentially over the R-Smad homotrmer. This 
occurs despite
Smad4 not having a phosphorylated C-terminus, and thus not being able to donate
phosphoserine residues to the L3 100p/P8 strand of its neighboring R-
Smad. Therefore
Smad4 is presumably able to contribute other favorable interactions that can compensate
for the loss of the interaction between the phosphorylated C-terminal tail and the loop-
strand pocket.
Therefore, to resolve the stoichiometrc identity of the heteromeric R-
Smad/Smad4 complex, and understand the basis for its preferential formation over the R-
Smad homotrmer, we determined the crystal strctue of both Smad3/Smad4 and
Smad2/Smad4 complexes. The strctures , in corroboration with fuctional studies
reveal the presence of unique favorable electrostatic interactions within the heteromeric
interfaces, and support a unifying mechanism ofheterotrmeric Smad assembly,
consisting of two R-Smads and one Smad4 , in TGF-p signaling.
MATERIALS AND METHODS
Reagents
The pTXB intein expression vector, 
E. coli strain ER2566, and chitin sepharose
beads were obtained from New England Biolabs. The phosphorylated peptides
corresponding to Smad2 residues 463 to 467 (Cys-Ser-pSer-Met-pSer) or Smad3 residues
421 to 425 (Cys-Ser-pSer-Val-pSer) were obtained from the UCSF peptide sequencing
facility.
Generation of phosphorylated Smad2 and Smad3
Phosphorylated forms of Smad2 and Smad3 were produced through an intein-
mediated peptide ligation (IPL) method (Figure 4- 1). PCR was used to generate
fragments of Smad2 and Smad3 containing the linker and MH2 domains with the 5 C-
termnal residues deleted (S3LCMail, residues 145-420 and S2LCMail , residues 186-
462). PCR-generated flaning NdeI and Sap! restrction sites were used to subclone the
fragments into the pTXB vector. 
E. coli ER2566 cells were transformed with
S3LC(.Mail)- or S2LC( tail)-pTXB and grown in trptone-phosphate media. Cells were
grown at room temperature to an optical density (600 nm) of 0. 7, and induced with
25 t-M IPTG, then allowed to grow for an additional 25-36 hours. Cells were
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Figure 4-1. Intein-mediated peptide ligation strategy used to generate phosphorylated
Smad3. Adapted from Muir, 2003.
harvested, lysed through sonication, and centrfuged to obtain the clarfied cell extract 
described in Chapter II. The cell extract was applied a chitin sepharose column. After
extensive washing of the column with chitin buffer (50 mM Na HEPES, 500 mM NaCl, 
mM EDT A), the column was flushed with approximately 100 mL of chitin buffer
containing 50 mM 2-mercaptoethanesulfonic acid (MESNA), and allowed to incubate for
16-40 hours at 4 C. Following the MESNA-induced cleavage, the cleaved protein was
eluted from the chitin sepharose column with chitin buffer (+50 mM MESNA). After
concentrating the eluted protein to --20 mg/ml (--667 M), the peptide corresponding to
the phosphorylated C-terminus (C- pS- pS for Smad3 and C- pS-
pS for Smad2)
was added in 4-fold molar excess. Following overnight incubation at 4
phosphorylated (trmeric) protein was separated from unphosphorylated (monomeric)
protein through size exclusion chromatography on the Superdex 200 column. Smad4AF
(S4AF, residues 273-552) was expressed and purfied as described in Chapter II.
Isothermal titration calorimetry
Binding of Smad4AF (273-552) to phosphorylated Smad2LC (186-467) or
phosphorylated Smad3LC (145-425) was measured by isothermal titration calorimetry
(Wiseman et aI., 1989) using a VP-ITC calorimeter (MicroCal, Northampton, MA). All
samples were dialyzed against ITC buffer (20 mM HEPES, pH 7.0, 100 mM NaCl, 0.
mM EDTA, 1 mM TCEP), and degassed prior to titration. Experiments were initially
performed at 25 C, but no binding enthalpy could be observed at this temperature.
Subsequent experiments at 37 C produced a measurable binding enthalpy. 100 
Smad2 or Smad3 was titrated by addition of 300 ""I of 400 ""M Smad4 over 30 injections.
Data was analyzed with Origin 7.0 software (MicroCal), assuming a one-site binding
model. H, S, and Ka values were experimentally determined, and G was calculated
from these values ( G = -RT In Ka = H - T S). Heat capacity ( ) values were
determned for S3(LC, 2P) by performing additional ITC experiments at 34 and 40
and calculating from HI T).
Differential scanning calorimetry
Differential scanning calorimetr measurements were conducted on a VP-DSC
calorimeter (MicroCal), with cell volumes of 0.5 mL. The protein concentration for all
samples was 1 mg/ml. Reversibilty of sample denaturation was examined though
comparson of thermo grams from consecutive DSC scans of the same sample. Scan-rate
dependence, or susceptibilty to time-dependent denaturation, was assessed by repeating
DSC runs at varing scan rates ranging from 5- C/h. All Smad protein constrcts
tested displayed ireversible thermal transitions and scan-rate dependence. Standard DSC
buffer used in most experiments was 20 mM HEPES, pH 7.0, 100 mM NaCl, 0. 1 mM
EDT A, and 1 mM TCEP, although experiments were performed in a varety of buffer and
denaturant conditions in an attempt to create thermodynamically reversible conditions.
Samples were dialyzed extensively against the DSC buffer and degassed prior to
experiment. Instrumental baselines were recorded by fillng both cells with buffer, and
were subtracted from the experimental traces to obtain heat capacity curves.
Deconvolution analysis of DSC curves was performed using Origin software (MicroCal)
with the assistance of Dr. Ashutosh Tiwar.
~~~" . ;;.
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Crystallization of phosphorylated R-Smad/Smad4 complexes and structure
determination
To form the heteromeric Smad complex, S4AF was added in 2-fold molar excess
to phosphorylated S2LC or S3LC. Each heteromeric Smad complex was first purified by
ion-exchange chromatography on a DEAE anion exchange column, during which the
uncomplexed Smad4 eluted in the flow-through fractions, while the heteromeric Smad
complex eluted in a 100-300 mM NaCI gradient. Since the resulting Smad complex
could not be crystallzed, it was subjected to limited chymotrypsin digest (1:100 w/w) for
24 hours on ice, and further purified by Superdex 200 size exclusion column
(Amersham). N-terminal sequencing and mass spectrometr analysis revealed that the
final heteromeric Smad complex lost most of the linker sequence as a result of the
chymotrpsin digest. Smad3 extends from residue Glu228 to the C-termnus. Smad2
extends from the equivalent residue Glu270 to the C-terminus. Smad4 contains residues
309 to the C-terminus in two fragments , as a result of a single internal chymotrpsin cut
after Leu484. Leu484 is located within a flexible, solvent accessible region connecting
helix 3 and helix 4 in the Smad4 MH2 domain structure.
Crystals of the chymotrpsin-treated S3(LC,2P)/S4AF and S2(LC,2P)/S4AF
complexes were obtained using the hanging drop vapor diffusion technique. The protein
solution (15 mg/ml) was mixed with an equal volume of well solution containing 50 mM
Tris-HCl (pH 7.5), 0- 15 mM MgCI , and 5- 15% ethanol. Crystals were transferred to a
cry solvent comprised of 24% glycerol and 76% well solution, and flash frozen in liquid
nitrogen. Diffraction data for the S3(LC,2P)/S4AF complex were collected at the
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BioCARS beamline at the Advanced Photon Source at Argonne National Laboratory.
Diffraction data for the S2(LC,2P)/S4AF complex were collected at - 170 C using an R-
Axis IV image plate system mounted on a Rigaku rotating anode generator, at a detector
distance of 200 mm with 1 oscilation per frame. Data were integrated and reduced using
DENZO and Scalepack (Otwinowski and Minor, 1997). The strctures were determined
by molecular replacement using the CNS software package (Brunger et aI., 1998), using
the phosphorylated Smad2 MH2 domain (Wu et aI., 2001b) as the search model. The
search located three MH2 domains in the asymmetrc unit, designated subunits A, B and
C, which arange in the same manner as the structures of the previously solved
crystallographic homotrmers of Smad4 (Shi et aI., 1997; Qin et aI., 1999), Smadl (Qin et
aI., 2001), and Smad2 (Wu et aI., 2001b. Examination of the initial2f electron density
map revealed features indicating that subunits A and C correspond to Smad3 while
subunit B corresponds to Smad4. For example, the electron density of the
phosphorylated C-termnal sequence of Smad3 is readily visible in subunits A and C but
is completely absent in subunit B. Also, extra electron density corresponding to the two-
residue insertion in Smad4 (Ser344 and Cys345) between the p2 and p3 strands was
present in subunit B but not in subunits A and C. The same observations were obtained
when the Smad4 MH2 domain monomer was used as a search model to locate the thee
subunits. Rigid body refinement of the three MH2 domain subunits using all possible
combinations of Smad3 and Smad4 also resulted in the same conclusion. The correct
combination of pSmad3-Smad4-pSmad3 , corresponding to subunit A- C, gave an initial
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free of 37.5%, while the next best combination, pSmad3-pSmad3-pSmad3, gave an initial
Rfree of 40.7%.
The initial solutions were furer refined though the CNS rigid body, simulated
annealing, and B-factor refinement protocols (Brunger et aI. , 1998). Structures were
rebuilt with CHAIN (Sack, 1998) and 0 (Jones et aI. , 1991).
Size exclusion chromatography
Size exclusion chromatography was used to analyze the interaction between
S3LC(2P) or S2LC(2P) and S4AF, or varous mutant forms derived thereof, as described
in Chapter II.
Immunoprecipitation and Western blots
Immunoprecipitations were performed by Dr. Gen Shi. COS- l cells were
transfected with the indicated constrcts with or without the activated type I TGF-p
receptor point mutant (T204D) Alk5 CA (Wieser et aI. , 1995). After 24 hours , cells were
switched to 0. 1 % serum overnight, and lysed in triton X lysis buffer (1 % trton X
150mM NaCl, 10% glycerol , 5mM EDT A and 25mM HEPES , pH 7.5) in the presence of
protease and phosphatase inhibitors. Lysates were either directly separated by SDS-
PAGE and transferred onto Immobilon-P membranes (Milipore), or first
immunoprecipitated for 2 hours using epitope specific rabbit anti-Flag antibodies
antibodies (Sigma), as indicated, and detected using the appropriate horseradish
(Sigma). Immunoblots were performed using mouse 9ElO anti-Myc or anti-Flag M2
peroxidase-conjugated secondary antibody, and visualized by chemiluminescence
(Pierce).
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RESULTS
Generation of phosphorylated forms of Smad2 and Smad3 and isothermal titration
calorimetry
Intein-mediated peptide ligation was used to generate phosphorylated forms of
Smad2 and Smad3 (Materials and Methods; Figues 4- 1 and 4-2A). Native-PAGE and
size exclusion chromatography (Figue 4-2B and 4-2C) were used to confirm that ligation
of the phosphorylated tail was successfully accomplished. The SEC elution profie of
phosphorylated S2LC and S3LC was consistent with trmerization, with the peak
occuring in fractions 14 and 15 , compared to fraction 20 for the unligated proteins. The
phosphorylated proteins were also tested for their ability to bind Smad4. SEC analysis of
1: 1 mixtures of phosphorylated S2LC or S3LC with S4AF revealed that these proteins
formed complexes with S4AF of apparent 2:1 stoichiometr, identical to the
pseudophosphorylated forms of Smad3 and Smadl described in Chapter II (Figues 4-
, and 2- 12).
Although the experiments described above and in Chapter II strongly support that
the R-Smad/Smad4 complex is a heterotrimer, this idea was contradicted by other studies.
Size exclusion chromatography analysis of endogenous Smad2/Smad4 complexes from
TGF-p-stimulated cells suggested that these complexes were heterodimers (Jayaraman et
aI. , 2000). Smad2 and Smad3 were also discovered to have very different endogenous
homo-oligomerization states in these studies. Using size exclusion chromatography and
analytical ultracentrfugation methods similar to those
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Figure 4-2. (A) Expression and purification ofSmad3LC( 421-425). Lane 1: Molecular
weight standards; Lane 2: Cell extract containing Smad3LC( 421-425)-intei CBD
fusion protein; Lanes 3 and 4: Washes following adsorption of the fusion protein to chitin
column; Lane 5: Fusion protein on chitin beads after washing; Lane 6: Fusion and
cleaved protein on chitin beads following 2-mercaptoethanesulfo ic acid-mediated
release of protein; Lane 7: protein as eluted from the chitin column.
(B) SDS-PAGE (left) and native-PAGE (right) ofSmad3LC( 421-425) prior to and
following the addition of the phosphorylated C-terminal tail. The shift in protein
migration on native-PAGE following addition of the phosphorylated C-
terminus indicates
that ligation has been achieved.
(C) Size exclusion chromatography elution profile of Smad2LC( 463-467) prior to
(dashed green line) and following (solid blue line) the addition of the phosphorylated C-
terminal tail. The shift in protein oligomerizatio state is indicative of successful peptide
ligation.
(D) SDS-P AGE of size exclusion chromatography of S3LC(2P) and S4AF, combined at a
I: I protein ratio (approximately 50 (lM each). Analysis of the fractions that eluted as a
complex (fractions 15- 17) through densitometr revealed that the ratio of S3LC(2P) to
S4AF was approximately 2: I.
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described in Chapter II , Wu and colleagues determined that the MH2 domains of Smad2
and Smad4 appeared to form heterodimers. However, an unphosphorylated version of
Smad2 was used in those studies (Wu et aI. , 2001a). These studies may suggest a
fudamental difference between the Smad3/Smad4 (heterotrmer) and Smad2/Smad4
(heterodimer) complexes , but analysis of nuclear extracts of cells transiently co-
transfected with differentially-tagged Smads revealed the opposite. Smad2 and Smad4
formed a heterotrimer when bound to the cofactors Fast-
l or Fast-3 and DNA, while the
DNA-bound Smad3/Smad4 complex was a heterodimer (Inman et aI., 2002).
Isothermal titration calorimetr (IT C) was used to analyze the stoichiometr and
the thermodynamics of binding of the phosphorylation-induced Smad3/Smad4 and
Smad2/Smad4 interactions (Table 4- 1; Figure 4-3). S4AF (400 M) was titrated into the
ITC sample cell containing either S2LC(2P) or S3LC(2P) (100 
M). Smad4 titrates both
S2LC(2P) and S3LC(2P) at a relative molar ratio of approximately 0.5, confirming the
stoichiometr observed from previous 
studies utilizing the pseudophosphorylated R-
Smad mutants (Chapter II). The apparent dissociation constant ( ) values are 60 nM for
Smad3/Smad4, and 300 nM for Smad2/Smad4. The change in Gibbs
' free energy (L\G)
resulting from complex formation is 
1 0 kcallmol for Smad3/Smad4 , and 9 kcallmol for
Smad2/Smad4 (Table 4- 1). However, it is important to note that S2LC(2P) and
S3LC(2P) exist as homotrmers prior to titration with Smad4, whereupon a monomeric
Smad4 subunit displaces a subunit in the R-Smad homotrimer to form the R-
Smad/Smad4 heterotrimer. Therefore the reaction heat that is detected by the calorimeter
r 't -
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Table 4-1. Summar of isothermal titration calorimetr of phosphorylated 
Smad3 and
Smad2 with Smad4.
Smad3/Smad4 Smad2/Smad4
50 :t 0.001 0.49 :t 0.011
H (kcallmol) 7.5 :t 0. 2:t 0.
S (callmollK) 8 :t 0.
7 :t 0.
G (kcallmol) 10.0:t 0. 1 :t 0.
Kd (nM) 58 :t 2. 296:t 165.
T(K) 310 310
S (kcal/mol) 728 1.147
370
Time (min) Time (min)
100 200 300 100
-0.
-0.
. -0.4
0.4
-0.
-0.
'0 -4
52/54 Molar Ratio 53/54
fvlar Ratio
Figure 4-3. Isothermal titration calorimetr analysis of the interaction between S4AF
and S2LC(2P) (left) and S3LC(2P) (right).
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is a difference between association and dissociation events , and the actual 
and AG of
the R-Smad/Smad4 interaction are likely to be more favorable than what is determined
from the ITC experiment. The change in free energy resulting from complex formation is
driven primarily by a highly favorable enthalpy (AH), although the Smad3/Smad4
interaction has a significantly more favorable entropy (T AS) term than Smad2/Smad4
(Table 4- 1). The slight difference in the thermodynamics of binding between these two
proteins, which are approximately 94% identical between their respective MH2 domains
is somewhat surrising, but may be partly explained by the approximately 16%
difference in sequence between the linker regions of the two constrcts. That
heteromeric complex formation is enthalpically driven indicates that preferential
interaction between R-Smads and Smad4 is primarily mediated by polar interactions
(Fersht et aI. , 1985; Bhat et aI. , 1994; Ye and Wu, 2000).
Crystal structures of phosphorylated Smad3(LC, 2P)/Smad4(AF) and
phosphorylated Smad2(LC, 2P)/Smad4(AF)
The constrcts used to analyze the R-Smad/Smad4 interaction in these studies
include the Smad MH2 domains , which mediate Smad oligomerization. The
phosphorylated Smad3 and Smad2 constrcts include the linker and MH2 domains. The
phosphorylated Smad3 constrct extends from residues 145-425 and is referred to as
S3LC(2P). The phosphorylated Smad2 constrct extends from residues 186-467 and is
referredto as S2LC(2P). The Smad4 constrct used comprises the MH2 domain and part
of the linker domain, extending from residues 273-552 , and is referred to as S4AF
, as
previously described in Chapters II and III of this thesis (Chacko et aI. , 2001). The
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heteromeric Smad complex consisting of S3LC(2P) and S4AF was obtained by
combining S4AF in 2-fold molar excess over S3LC(2P) in solution, then separating the
complex from free S4AF through size exclusion chromatography. Attempts to crystallize
this complex were unsuccessful. The complex was then subjected to a limited
chymotrsin digest (see Materials and Methods) and fuer purified through size
exclusion chromatography. This chymotrsin treatment produced a form of the
complex that yielded diffraction-quality crystals. SDS-P AGE, N-terminal sequencing,
and mass spectrometr analysis revealed that the final heteromeric Smad complex lost
most of the linker sequence as a result of proteolysis. In the crystal strcture
, Smad3
extends from residue 228 to the C-terminus. Smad4 contains residues 309 to the C-
terminus in two fragments , as a result of a single internal chymotrsin cut after Leu484.
Leu484 is located within a flexible , solvent accessible region connecting helix 3 and 4 in
the Smad4 MH2 domain strctue (Figue 4-4). This region is presumably also flexible
in the heteromeric Smad complex, as indicated by its susceptibility to chymotrsin
digestion. An identical method was used to produce a crystallzable form of the
Smad2/Smad4 complex. Both strctues were solved through molecular replacement
using the previously solved strctue of phosphorylated Smad2 (Wu et aI. , 2001b) as a
search model (see Materials and Methods and Table 4-2). The Smad3/Smad4 strcture
was refined to 2.5 A, and the Smad2/Smad4 strctue was refined to 2.8 A. The crystal
strctues reveal that both protein complexes are heterotrmeric , consisting of two R-
Smad subunits and one Smad4 subunit (Figue 4-5). This is in agreement with our prior
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Smad2 LDLQPVTYS EPAFWCSIA YYE LNQRVG ET FHASQ- - - PS L TV DGFT DP- SNS - ERF 
C LG L LS NV NRNA TV EMTRRHIGRGVRL YY 340
Smad3 LDLQPVTYC EPAFWCS I SYYE LNQRVGET FHASQ- - -
P5MTVDGFT DP- 5NS - ERF C LG L L SNVNRNAAV E L TRRHI GRGVRL YY 298
Smadl - DVQA V AYE E PKHWCS IVYYE LNNRVGEA F HA 55 - - - T 5V L VDGFT DP- 5NNKNRF C L 
G L L5NVNRN5 T I ENTRRHI GKGVHL YY 338
Smad5 - DVQPV AYE E PKHWCS IVYYE L NNRVG EA F HA 5 5 - - - T 5V L VDG FT DP - 5N N K 5RF C L 
G L L 5 NVNRNS TIE NTRRHI GKGVH L YY 338
Smad4 FQPPISNHPAPEYWCS IA YF EMDVQVGET F KV PS 5 - 
CPIVTVDGYV DP - 5 - G GDRF C L GQL 5NVHRT EAI ERARL HI G KGVQLEC 391
Mad - DV AQVSYSEPAFWASIA YYE LNCRVGEV F HCNN - - - NSV IVDGFTNP - SNNSDRC C LGQL 
SNV NRNST I E NTRRHI GKGV HL YY 328
Sma-2 - PFDKVW- - E EQFWA TVSYYE LNTRVGEQV KVSS - - - TT IT 
IDGFTDP- CI NGSKI 5 LG L F SNV NRNA TI ENTRRHI GNGVKL TY 289
Sma-3 - - - RPPPFRHPKSWAQITYFE LNSRVGEV FKL VN - - - LSITVDGYTNP- SNSNTRI C 
LGQL TNV NRNGTI ENTRMHIGKGIQLDN 264
Sma-4 QIYVPT PPQL LDNWCSI IYYE LDTPI G ET FKVSARDHGKV IVDGGMDPHGE N EGRL C LGAL SNVHRT 
EASEKARI HI GRGV EL T - 420
. . 
Smad2 1- - GGEVFAECLSDSAIFVQSPNCNQRYGWHPA- TVC
Smad3 1- - GGEVFAECL SDSAI FVQSPNCNQRYGWHPA- TV C
Smadl V - - GGEVY AECL SDSSI FVQSRNCNYHHGF HPT - TVC
SmadS V--GGEVYAECLSDSSIFVQSRNCNFHHGFHPT - TVC
Smad4 - KGEGDVWVRCL SDHAV FVQSYYLDREAGRAPGDAVH
Mad V - - TGEVYAECL SDSAI FVQSRNCNYHHGFHPS- TVC
Sma-2 VRSNGSLFAQCESDSAI FVQSSNCNYI NG FHST - TVV
Sma- 3 KEDQMHIMITNNSDMPVFVQSKNTNLMMNMPL V - KVC
Sma-4 AHADGNISIT - - SNCKI FVRSGYLDYT HGSEYSSKAH
PPG- CNLKIFNNQ- EFAALLAQ- - - - - - - 
-- - - - - - - - - - - - - -
- - 396
PPG- CNLKI FNNQ- EFAALLAQ- - - - - -- - 
- - - 
- - - - - - - 354
IPSG- CSLKIFNNQ- EFAQLLAQ- - - - - -- 
 - - - 
---- - 394
PS5- CSLKIFNNQ- EFAQLLAQ- - ----- 
- - - - -- -
-- - 394
YPS - AYI KV FDLR-QCHRQMQQQAA T AQAAAAAQAAAV AGNI PGPG 473
PPG- CSLKIFNNQ- EFAQLLSQ- - ----- 
-- -  - - - -  - 
---- 384
ANK- CSLKIFDME- IFRQLLED- - - - - -- 
 -
- -- - - - - 347
PPH- SQLCVFEFN- LFFQMLEQ- - 
--- - -   
- - - - - - - - - - - -- - - 323
FTPNESSFTV FDIRWA YMQML - RRSRDSNEAVRAQAAAV AGYAPMSV 502
Smad2 - - -- - - - - - - SVNQGFEAVYQL TR-MCTIRMSFV WGAE
Smad3 -
--- -----
-SVNQGFEAVYQL TR-MCTIRMSFV WGAE
Smadl ---------- SVNHGFETVYELTK-MCTIRM5FV WGAE
Smad5 - SVNHGFEAVYELTK-MCTIRMSFV WGAE
Smad4 SVGGIAPAIS LSAAAGI GVDDLRR- LCI LRMSFVKGWGP
Mad - 
 - -  - - - - - 
SVNNGFEAVYE L TK- MCT IRMS FV WGAE
Sma-2 ---------- CSRRGFDASFDLQK-MTFIRMSFV WGAE
Sma-3 --------- SCNDS- DGLNELSK- HCFIRISFV WGE
Sma-4 M--------- PAIMPSSGVDRMRRDFCTIAISFV WGDV
Figure 4-4. Structure-based sequence alignment of the MH2 domains of the Smad
proteins. The secondar structural motifs are shown below the alignment. Residues in
Smad4 and Smad2 known to be mutated in cancer are highlighted in yellow. 
Sites of
phosphorylati are shown in green. Residues coordinating the phosphorylated tail are
highlighted in red. The Smad4-specific insertion is located between helix 3 and helix 4
(residues 450-488). Smad4 residues 456-489 are missing in the S2/S4 and S3/S4
strctures described in this chapter. Adapted from Wu et aI., 
2001b.
Table 4-2. Summar of crystal analysis for Smad2(LC,2P)/Smad4(AF) and
Smad3(LC,2P)/Smad4(AF)
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Parameter S4AF
Crystal parameters and crystallographic dataSpace group P2(1)2(1)2(1)Unit cell dimensions a = 49.
b = 59.
c = 207.44
100- 8 (2.
78952
15933
85.3
14.4
Diffraction limit (At
Total reflections
Unique reflections
Completeness (%)
Intensity/Sigma
merge 
(%)b
S3(LC.2P)/S4AF
P2(1 )2(1 )2( 1)
a = 48.47
b = 60.
c = 205.
100- 5 (2.
89892
16539
96.5
17.
Refinement statistics
Protein atoms 4777 4985
R factor (% 
24. 23.
Rfree factor (%)d 27. 24.
Rms deviation from ideal
Bond lengths (A) 0106 0079
Bond angles (0 1.590 658
factor rms deviation
Main chain (A 960 1.445
Side chain (A 4.410 1.742
Values in brackets are for the highest resolution shell.
Rmerge = hkl-.clhkl I/L Ihk,
R factor = Lhkl IIFobs ealell/Lhk IFobsl for all data.
R free = Lhk, IIFobs ealell/Lhkl IFobsl for 10% of the data not used in refinement.
....
Rf.
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biochemical analysis that showed, using acidic amino acid substitutions to mimic
phosphorylatio , that the Smad3/Smad4 and SmadllSmad4 complexes were
heterotrmers (Figure 2- 11; Chacko et aI., 2001; Qin et aI., 2001). The R-Smad subunits
in both crystal structures were designated subunits A and C, and the Smad4 subunit was
designated subunit B. These three subunits arange in a manner similar to the 
strctures
ofthe previously solved homotrmers of Smad4 (Shi et aI., 1997; Qin et aI., 1999),
Smadl (Figure 3-6; Qin et aI., 2001), and Smad2 (WU et al., 2001b) (Figure 4-
Overall Structure of the R-Smad/Smad4 Heterotrimer and Interface Analysis
Each of the subunits of the R-Smad/Smad4 heterotrimeric complex consists of a
central p sandwich flaned on one side by three helices (thee-helix bundle) and on the
other side by three loops and another helix (loop-helix region). The previously solved
homotrmeric strctues ofSmadl (Qin et aI. , 2001) and Smad2 (Wu et aI. , 2001b)
revealed that subunit-subunit contact is mediated specifically by the interaction of helix
, helix 5 , and the phosphorylated C-terminal tail of one subunit with helix I
, the p4
strand, and the L3 100p/P8 strand pocket, respectively, of a neighboring subunit. This
general featue of interface formation is conserved in the R-Smad/Smad4 heterotrmer
with the exception that there are only two phosphorylated C-terminal tail interactions in
the heterotrmers , one between subunit A and B and the other between subunit C and A
due to Smad4 lacking a phosphorylated tail (Figure 4-7 and 4-8). In addition, Smad4
possesses a unique conformation that results in closer contacts between subunits B and C
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Figure 4-5. Overall structure of the R-Smad/Smad4 heterotrmeric complexes. 
(A)
Smad2(LC, 2P)/Smad4(AF) complex. (B) Smad3(LC, 2P)/Smad4(AF) complex. The R-
Smad subunits are designated A and C. The L3 loops are in yellow, with the C-
terminal
sites of serine phosphorylation depicted in stick representation.
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in the heterotrmer. Superposition ofthe heterotrmer subunits to those of the previously
solved Smad2 homotrmers (WU et aI. , 200 1 b) reveals that the thee-helix bundle of
Smad4 subunit in the heterotrimer undergoes a significant shift toward the neighboring
Smad subunit when compared to the corresponding subunit in the Smad2 homotrmer
(Figue 4-6). The unique conformation of Smad4 likely results in improved contacts
between subunits B and C interactions that contrbute to the preferential formation of the
Smad/Smad4 heterotrmer over the R-Smad homotrmer.
To gain insights into the strctural mechanism of preferential heterotrmer
formation, the interface contacts of the heterotrmeric crystal strctues were compared
with those of the previously solved crystal strcture of the Smad2 homotrimer. The
presence of Smad4 in the heterotrimer results in three interfaces that are distinct from
each other, designated AB (between subunit A and B), BC (between subunit B and C),
and CA (between subunit C and A). This is in contrast to the Smad2 homotrmer, which
contains three identical interfaces. Since the strctues of the Smad3/Smad4 and
Smad2/Smad4 heterotrimeric complexes are virtally identical, with an overall rms
deviation of only 1.5 A, most of the strctual analysis described below was done on the
higher resolution Smad3/Smad4 strctue. Overall, there appear to be fewer hydrogen
bond interactions in the BC and AB interfaces compared to the homotrmeric interfaces
although all three heterotrmeric interfaces possess a common subset of hydrogen bond
interactions that are also present in the homotrimeric strcture (Table 4-3). Most notably,
Smad4 possesses unique amino acid residues not present in the R-Smads that result in
new electrostatic interactions in the BC and AB interfaces. These favorable electrostatic
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Figure 4-6. Superposition of the alpha carbon traces of the Smad2 homotrimer (gray)
and the Smad3/Smad4 heterotrmer. The Smad3 subunits ofthe heterotrimer are depicted
in green, the Smad4 subunit in blue. (Inset) Close-up view of helix 3 and helix 4 ofthe
Smad4 (B) subunit ofthe Smad3/Smad4 heterotrmer and the superimposed 
Smad2
homotrmer. Helix 3 is located above helix 4. Helix 5 of both strctues is 
removed for
clarity.
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ad3/S ad4 ete faces
Smad2 Homomeric Interface C A Interface
BC Interface AB Interface
Smad2 Smad2 Smad3
Smad3 Smad4 Smad3
Smad3 Smad4
N283 0 N320 00 N24\ 0 N278 00
03320 N278 00
N283 NO N320 00 N241 ND N278 00
0332 00 N278 00 N241 NO H371 NE
H29\ NE E2880t: H249 NE 46 OE
K340 NZ E246 OE
Y406 OH 9 NH YJ64 OH
87 Nil
Y3640H RJ80 NH
Q407 OE R330 NH
E439 OE S3 J7 OG E397 OE
S2750G E5160E S2750G E397 OE
S3680G
H441 NE S3170G H399 NE S2750G
H528 NE S2750G H399 NE S368 OG
L46 0 T303 OG L404 0 T261 OG
L533 0 T26\ OG
447 NE 03040D 405 NE D261 OD
534 NE D262 OD 405 !\TE D355 OD
447 NE S3060G 405 NE 52640G
.'34 NE 5264 00 0405 NE 5357 OG
D450 N T303 OG 0408 N
T261 OG D537 N T26\ OG
D450 OD R3JONH D408 aD
68 NH D537 OD R268 NH
D'108 aD R361 NH
0450 00 T303 N 0408 00 T261 N
0537 00 T261 N
0450 00 D304 N 0408 00 D262 N
0537 aD D262 N D408 00 0355 N
V4610 H331 NE 14190 H289 NE
14190 H382 NE
S464 0 K420 NZ 5422 a K378 NZ
pS465 a G421 N pS423 0 G379 N
pS423 0 G508 N
pS465 OP K375 NZ pS423 OP
K333 NZ
pS423 OP K428 NZ
pS465 OP Y 426 OH pS423 OP
Y384 OH
pS423 OP Y513 OH
pS467 OP K420 NZ pS425 OP
K378 NZ
pS425 OP K507 NZ
pS467 0 K420 NZ pS425 0 K378 NZ
pS467 0 R427 NH
pS467 a R428 NH pS425 0 R386 NH
pS425 a R515 NH
*E361 OE R288 NH
*0493 00 R279 NH
*0493 00 R287 NH
T338 OG E246 OE T247 OG
E337 OE
T247 N E3370E
pS425 OP R378 NE
1'5425 K,78 NH
Table 4-3. Hydrogen bond comparison between the Smad2 
homotrmer interfaces and
the three Smad3/Smad4 heterotrimer interfaces. Hydrogen bonds that are conserved
between the R-Smad homotrimer and R-Smad/Smad4 
heterotrmer interfaces are boxed.
Residues that are conserved in all four interfaces are shown in red. 
Interactions that are
unique to one interface are marked with an asterisk. A soft cut-off distance of 3.
5 A was
used.
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interactions appear to compensate for the fewer hydrogen bonds, accounting for the
favorable enthalpy change upon hetero-oligomerization.
Asp493 of Smad4 coordinates a buried electrostatic interaction in the BC Interface
The smaller number of hydrogen bonds in the BC interface is due largely to
Smad41acking a phosphorylated C-terminal tail; therefore the interaction between the
phosphorylated tail and L3 100p/P8 strand pocket that is characteristic of the R-Smad
homotrmeric interfaces is not present at this interface (Figues 4-7 and 4-8). Despite the
lack of a phosphorylated tail, and the corresponding reduction in number of hydrogen
bonds , the most strking featue of this interface is a network of salt bridges and hydrogen
bonds centered on Asp493 of helix 4 ofthe Smad4 (B) subunit. Asp493 is situated in the
center of four arginine residues , Arg3211279 and Arg329/287 (in this convention, the
residue number for Smad2 is on the left, Smad3 is on the right) of the C subunit, and
Arg496 and Arg497 of the B subunit (Figues 4-8 and 4-9). Asp493 is able to form
intermolecular salt bridges with the two arginine residues of the C subunit, as well as an
intramolecular salt bridge with Arg496. In addition, the backbone oxygen of Asp493
forms an intramolecular hydrogen bond with Arg497 (Figue 4-8). Asp493 appears to
coordinate the positive charge contrbuted by the four surrounding arginine residues
maintaining a charge balance that allows the interface to form. Asp493 of Smad4 is
frequently found to be mutated in pancreatic and other cancers (Hahn et aI. , 1996),
suggesting that this residue has a crucial role in mediating Smad-dependent signaling.
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Q447 5306
D304 D450
Figure 4-7. Representative interface from the Smad2 homotrimer 
strcture solved by
Wu et aI., 200 1 b. The three helix bundle of the C subunit is shown in green
, and the
interacting loop-helix region of the A subunit is shown in orange. This interface is
identical between all three subunits in R -Smad homotrmers.
D493
Helix 4 (B)
Homotrimer interface Heterotrimer BC interface
Helix 1
(Smad2)
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(previous page) Figure 4- 8. (A) Smad3/Smad4 BC interface. The Smad4 (B) subunit is
depicted in blue, and the Smad3 (C) subunit is depicted in purple. (B) Close-up view of
the helix 4-helix 1 interaction in the Smad2 homotrmer (left) and the BC interface of the
Smad2/Smad4 heterotrmer (right). The presence of the asparic acid at position 493 of
Smad4 (as opposed to Tyr406 of Smad2), coupled with the shift in helix 4, results in
highly favorable electrostatic interactions between Asp493 and four surounding arginine
residues. This results in significantly improved interface contacts over those in the
Smad2 homotrmeric interface.
Figure 4-9. Electrostatic representation of D493 and surrounding residues of the B
subunit (left) and the adjacent interacting residues in the C subunit (right). The lone
asparic acid residue at position 493 of Smad4 forms intermolecular salt bridges with two
arginines of the C subunit (R279 and R287), an intramolecular salt bridge with R496, and
an intramolecular hydrogen bond with R497.
le-
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To examine the role of Asp493 in the R-Smad/Smad4 interaction
, the ability of a
D493A mutant to form heterotrmeric complexes was analyzed through size exclusion
chromatography and ITC. As opposed to wild-tye S4AF, 
S4AF(D493A) did not co-
elute with S3LC(2P) or S2LC(2P) on the size exclusion column, indicating that the
Smad4(D493A) mutant is unable to interact with phosphorylated R-
Smads to form
heterotrmers (Figue 4-10A). The potency of this mutation is underscored by ITC
experiments , which showed that S4AF(D493A) has very little interaction (
= 2.
H = -3 kcallmole) with S3LC(2P) (Figue 4-10B). These results were 
fuher confirmed
by immunoprecipitatio experiments. COS cells were transfected with full-
length
versions of Smad2 or Smad3, with full-length WT Smad4 or the Smad4(D493A) mutant
in the presence or absence of a constitutively active TGF-p 
tye I receptor (Wieser et aI.,
1995). Immunoprecipitation of Smad2 or Smad3 revealed that the Smad4(D493A)
mutant did not associate with either R-Smads
, unlike wild-tye Smad4 (Figue 4- 11). As
discussed in Chapter II, previous biochemical analysis has suggested a dimeric model for
phosphorylation-dependent Smad2/Smad4 interaction
, consisting of only subunit A and
B. This model would predict that Asp493 of Smad4 would not 
playa role in heteromeric
Smad assembly, as it is located on the surface that is not in contact with the R-
Smad. The
critical role of Asp493 of Smad4 revealed here strongly opposes the heterodimeric
model. The heterodimer between unphosphorylated 
Smad2 and Smad4 observed in other
studies (Wu et aI. , 2001a) could be the product ofthe highly favorable interaction
between the Band C subunits in the crystal 
strcture. It is likely that the potent
electrostatic interaction in the BC interface allows formation of an intermediate
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heterodimeric complex even in the absence ofR-Smad phosphorylation, while
phosphorylation drives the complex toward trimerization.
The residue in the position equivalent to Asp493 in the R-Smads is Tyr406/364.
This residue forms a hydrogen bond with Arg3291287 in the R-Smad homotrimer (Figure
7; Table 4-3). Of the four arginine residues that interact with Asp493 ofSmad4
, three
are conserved in the R-Smads (Figures 4-7 and 4-8B). Therefore it appears possible that
replacement of the R-Smad helix 4 tyosine residue (Y364) with aspartic acid might
approximate the heterotrmeric BC interface, thus resulting in a stronger homotrmeric
interaction. To test this possibility, we mutated Tyr364 to aspartic acid in
unphosphorylated S3LC, and analyzed the behavior of this protein on the size exclusion
column (Figue 4-12). Wild-tye S3LC elutes as an apparent monomer, with the peak
occuring at fraction 19. The S3LC(Y364D) mutant formed high molecular weight
aggregates , with the elution peak at fraction 9. The S3LC(Y364D) mutant was also
incapable of forming heteromeric complexes with Smad4 (data not shown). The results
suggest that this sale tyrosine to aspartic acid mutation is sufficient to produce a
significantly stronger homomeric interaction. Although the Y364D mutation did not
result in trmer formation, it is likely that the presence of the buried asparic acid residue
in the homomeric interface results in a strong charge interaction with surrounding
arginines , leading to aggregate formation. Taken as a whole, the data show that the
electrostatic interactions mediated by Asp493 of Smad4 contrbute to the preferential R-
Smad/Smad4 heterotrmer formation over R-Smad homotrimer.
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S3LC(2P)
S4AF(D493A) (BC interface)
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Model: OneSites
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Figure 4-10. (A) SEC analysis of interaction between S4AF or D493A mutant with
S3LC(2P) or S2LC(2P). (B) ITC analysis of S3LC(2P)/S4AF(D493A) interaction.
Smad4 Myc
Alk5 CA
IP 
Flag
IB Myc
IB Flag
Lysate IB Myc
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Flag Smad2 Flag Smad3
WT WT D493A D493A WT WT D493A D493A
Smad4
Smad4
Smad 2/3
Figure 4-11. Co-immunoprecipitation analysis of Smad2/Smad4 and Smad3/Smad4
interaction. COS- l cells were transfected with full-length wild-tye versions of Flag-
tagged Smad2 or Smad3 with or without Myc-tagged Smad4 or the Smad4 (D493A)
point mutant, and with or without the constitutively active TGF -p type I receptor point
mutant (T204D) Alk5 CA (Wieser et aI. , 1995). Complexes were immunoprecipitated
from cell extracts with an anti-Flag antibody and stained as indicated.
45k
31k
S3LC (wt)
S3LC
(Y364D)
Fraction 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Figure 4-12. Size exclusion chromatography analysis of wild-tye Smad3(LC) and
S3LC(Y364D). Fraction numbers are indicated on the bottom. The Y364D mutation
induces the formation of high molecular aggregates in Smad3.
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In addition to the favorable electrostatic interactions, the BC interface also
displays better interface packing compared to the R-Smad homotrmeric interfaces.
Interface shape complementarity was measured using the gap volume index statistic from
the Protein-Protein Interaction Server (Jones and Thornton, 1996). This statistic is a ratio
of the interface gap volume to interface bured surface area. More complementary
interfaces are indicated by a smaller gap volume index. The gap volume index value for
the heterotrmeric BC interface is 2. , compared to 2.48 for the Smad2 homotrmeric
interface. However, the slightly smaller value for the homotrmer is due largely to the
favorable interactions between the phosphorylated C-terminal tail and the L3 100p/P8
strand pocket. Deletion of the 5 C-terminal residues ofR-Smads results in a homotrmer
interface gap volume index of3.35. This indicates that the core interaction of helices 4
and 5 of Smad4 and helix 1 and the p4 strand of Smad3 in the heterotrmer is
significantly tighter than the equivalent interaction in the R-Smad homotrmer. The
improvement in surface complementarity of the BC interface is due in par to a shift in
the helices 4 and 5 of the thee-helix bundle of Smad4 in the heterotrmer as compared to
the homotrmer, as described above (Figue 4-6).
Arg378 of Smad4 reinforces phosphoserine binding in the AB Interface
The AB interface of the R-Smad/Smad4 heterotrmer also contains fewer
hydrogen bonds than the R-Smad homotrmeric interfaces , primarly due to the lack of
hydrogen bond interactions between helix 4 (A subunit) and helix 1 (B subunit), which
are present in all Smad interfaces except this one (compare Figures 4- , 4- , and 4-
with 4-13). The unique featue of this interface is the presence of an extensive hydrogen
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phosphotail (A)
R515
R361
Figure 4-13. The AB interface of the Smad3-Smad4 crystal strctue. The three-
helix
bundle of the Smad3 A subunit is depicted in green. The loop-helix region of the Smad4
B subunit is depicted in blue. The lack of hydrogen bonds between helix 4 and helix I is
seen only in this interface, but is parly compensated for by the hydrogen bonds mediated
by R378 of helix I with the phosphorylated tail of the A subunit.
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4=- bond interaction network between Arg378 (helix 1) of the Smad4 subunit and the tail
phospho serine residue at position 467/425 of the A subunit. This interaction occurs in
the R-Smad/Smad4 heterotrmer, but not in the R-Smad homotrmer because the
corresponding arginine residue is not conserved in the R-Smads (Figure 4-4). The
presence of Arg378 appears to make Smad4 a better receptor for the phosphorylated C-
terminal tail ofthe adjacent R-Smad subunit (A subunit) by increasing the basic
electrostatic potential surface of the phosphoserine binding pocket (Figue 4-14). This
additional helix l/phosphorylated tail interaction likely compensates for the lack of
hydrogen bonds between helix 4 and helix I.
The importnce of Arg378 was confirmed by mutating Arg378 to alanine and
analyzing the effect of the mutant on heteromeric interaction with the phosphorylated R-
Smads. S4AF(R378A) is able to only weakly interact with S3LC(2P), as evidenced by its
decreased co-elution with S3LC(2P) and S2LC(2P) on the size exclusion column
compared to wild-tye S4AF (Figure 4- 15A). This result was supported by ITC analysis
which showed that the ability of the S4AF(R378A) mutant to interact with
phosphorylated Smad2 or Smad3 was substantially reduced from the wild-tye protein
= 790 nM) (Figue 4- 15B).
The overall packing of the AB interface is similar to that of the homotrmeric
interface as indicated by the gap volume index statistics. The gap volume index for the
AB interface is 2.42 , which is comparable to the value for the homotrmeric interface.
Despite the similarity in the packing statistics, the AB interface is slightly more non-
polar
than the other interfaces. While the hydrophobic content of the BC, AC or the R-Smad
I,:
II:
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Figure 4- 14. Representation of surace electrostatic potential of phosphorylated C-
terminal tail interaction with L3 100p/P8 strand pocket in (A) Smad3/Smad4 AB interface
and (B) Smad2 homotrmer interface. The presence ofR378 in helix 1 ofSmad4 results
in an improved interaction with the phosphorylated tail.
45k
31k
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Figure 4- 15. (A) SEC analysis of interaction between S4AF or R378A mutant with
S3LC(2P) or S2LC(2P). (B) ITC analysis of S3LC(2P)/S4AF(R378A) interaction.
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homomeric interfaces are between 50 and 53%, the AB interface has a 57% hydrophobic
content, due to the higher percentage of hydrophobic residues 
contrbuted by Smad4.
Thus it is possible that the hydrophobic effect in the AB interface also contrbutes to
favorable heteromeric Smad assembly. Two residues that contrbute to the slight increase
in hydrophobicity of the AB interface are Va1354 (Ll100p, Thr 303/261 in Smad 2 and
Smad3) and Leu381 (Helix 1 , Arg 330/288 in Smad2 and Smad3). Both of these residues
mediate hydrophobic contacts in the AB interface of the heterotrmer that are not present
in the equivalent positions of the homotrimer interfaces. Leu381 
of helix 1 ofSmad4 sits
in a pocket surounded by R-Smad residues Phe402/360 and Tyr 406/364 of helix 4 (data
not shown). Therefore, although there are no hydrogen bonds between helix 4 and helix
1 of the heterotrimeric AB interface, this is at least partially compensated by the presence
of unique hydrophobic interactions between the two helices. In addition
, Val 354 in loop
1 ofSmad4 forms a van der Waals network with three leucine residues (Leu 446/404
449/407, and 453/411) of the neighboring R-Smad helix 5.
The CA Interface Resembles the Homotrimeric Interface
The CA interface formed by two R-Smad subunits is the only interface that is
conserved in both the homotrmer and heterotrmer, and is essentially identical in both
strctues. The hydrogen bond networks that mediate the interaction of helix 5 and the
phosphorylated tail of the C subunit with the p4 strand and L3 
100p/j38 strand pocket 
the A subunit are nearly the same between homotrmer and heterotrmer (Figues 4-
7 and
15A). A subtle difference in the two interfaces is found in the hydrogen bonds present
between helix 4 (C subunit) and helix 1 (A subunit). The hydrogen bond that exists
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between Gln407 (helix 4) of the C subunit and Arg330 (helix 1) ofthe A subunit of the
Smad2 homotrmer is not present in the heterotrmer, but is replaced by an apparent salt
bridge between Glu403/361 (Smad2/Smad3) of the C subunit with Arg330/288 of the A
subunit (Figure 4- 15B). Gln407/365 remains involved in the heterotrimeric interface by
forming an intramolecular hydrogen bond with Glu403/361. In the homotrmer
Glu403/361 is positioned toward the solvent, and therefore has no role in the
homotrmeric AC interface. In the heterotrmer, however, Glu403/361 undergoes a
conformational change that causes its side chain to flp approximately 6 A to come in
contact with Arg330/288 of the adjacent A subunit. However, mutation of Glu361 to an
alanine residue does not result in a significant defect in the phosphorylation-induced R-
Smad/Smad4 interaction as determined through gel fitration. ITC analysis revealed only
a 2 to 3-fold increase in Ki compared to wild-tye (data not shown). The result indicates
that the conformational change of Glu403/361 in the AC interface, and its associated
change in hydrogen bonding pattern, does not have a salient effect on the preferential
formation of the heterotrimer over the homotrimer. This suggests that the primar drivers
of preferential R-Smad/Smad4 heterotrimer formation are the electrostatic interactions
mediated by the Smad4 residues Asp493 and Arg378 of the BC and AB interfaces
respectively.
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Homotrimer interface Heterotrimer CA interface
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Figure4-16. (A) The CA interface ofthe S3LC(2P)/S4AF heterotrmer. (B)
Comparision between the R-Smad/-Smad helix 4-helix 1 interaction in the Smad2
homtrimer (left) and the equivalent interaction in the Smad2/Smad4 heterotrmer (right).
The flpping ofE403/361 results in a novel salt bridge interaction at this interface.
133
Structural stabilzation of R-Smads by Smad4 in the heterotrimer
The thermal stabilty of Smad3 and Smad4, both individually and in complex, was
assessed through differential scanning calorimetr (DSC) (Figure 4- 17). The scan range
used was 5 to 95 C. Initial DSC scans of S3LC and S3LC(2P), as well as S4AF,
revealed that both proteins displayed ireversible denaturation after heating to 95
Furthermore, both proteins displayed scan rate dependence, i.e., the DSC thermogram
vared widely depending on temperature increment used. Because of the thermal
ireversibilty and scan rate dependence of the proteins, equilbrium thermodynamic
analysis could not be performed. Therefore the data obtained could not be used to
calculate the ratio of calorimetrc enthalpy (AReal), and the unfolding transition curves
could only be compared in terms of peak transition temperature (T m)' We determned
that heating the proteins at a rate of 5- C/h resulted in optimal reproducibilty and
differentiation between the varous samples.
DSC analysis of unphosphorylated S3LC (residues 145 to 425) revealed that this
protein had a Tm of 48. C (Figure 4- 17B). The phosphorylated form, S3LC(2P),
displayed an identical peak T m of 48. C, however, the emergence of a trailng left edge
(compare "Smad3 monomer" and "Smad3 trmer" peaks in Figure 4- 16A) indicated that
decomposition of the Smad3 trmer occurred prior to unfolding of the protein (Figure 4-
17C). Deconvolution analysis revealed that the trmer to monomer transition occured at
approximately 45. C. DSC analysis of the Smad4 constrct S4AF (residues 273 to
552), revealed that it unfolded at a significantly higher temperature (T = 59.4)
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Figure 4- 1'. (A) Overlay of heat capacity curves of unphosphorylated S3LC
(magenta), phosphorylated S3LC(2P) (black), S3LC(2P)/S4AF heterotrmeric
complex (blue), and S4AF (red), (B)-(E) Heat capacity cures of
unphosphorylated S3LC, phosphorylated S3LC(2P), S4AF, and the heterotrmeric
S3LC(2P)/S4AF complex. Deconvolution of each curve is shown in red.
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than the Smad3 constrcts (Figure 4-17D).
The increased thermal stabilty of Smad4 relative to Smad3 appears to be due to
stronger intramolecular interactions in Smad4. It is possible that increased hydrophobic
interactions plays a role, as the S4AF constrct is composed of approximately 13% more
nonpolar residues than S3LC. As the numerous Smad crystal strctures have shown , the
MH2 domains of R-Smads and Smad4 are very similar strcturally, comprising a core p-
strand sandwich that is capped by a three-helix bundle on one end and a loop-helix region
on the other end (Shi et aI., 1997; Qin et aI., 1999; Wu et aI., 2001b; Qin et aI., 2001).
Aside from the phosphorylated tail, the major structural difference between the two Smad
classes is the presence in Smad4 of a specific insertion between helix 3 and helix 4, rich
in glutamine and alanine residues (Qin et aI. , 1999), and the increased thermal stability of
S4AF relative to S3LC may be a product of this insertion as well. Additional analysis
wil be required to determine the precise basis for this phenomenon.
Analysis of the thermal unfolding of the (phosphorylated) S3LC(2P)/S4AF
heterotrmeric complex reveals that the presence of Smad4 in the complex contrbutes an
increased stabilty to the Smad3 subunits within the complex (Figure 4- 17E). The heat
capacity curve reveals two distinct unfolding events, Smad3 unfolds first, followed by
Smad4. Deconvolution of the fIrst peak on the curve indicates that it is the sum of two
distinctendothermc processes, the breakdown of the heterotrmeric complex and the
thermal unfolding of phosphorylated Smad3. The T m of the deconvoluted curve that
corresponds to the thermally-induced dissociation of the Smad3/Smad4 complex appears
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to occur at 49. 1 oC. Furthermore, the T m of unfolding for Smad3 in the heterotrmeric
complex is 50. C, up from 48. C in the Smad3 homotrmer. These results appear to
show that Smad4 impars significant thermal stabilty to the Smad3 subunits in the
heterotrimeric complex , increasing both the T m of trimer dissociation as well the
unfolding temperature of Smad3. Given that Smad4 is intrnsically more thermostable
than Smad3, it appears that Smad4 may be serving as a sort of heat sink, drawing external
heat away from Smad3, allowing Smad3 to exist in a folded state slightly longer than it
can as a monomer or homotrmer. More study wil be needed to assess whether the
increased thermal stabilty of the R-Smad/Smad4 heterotrmer over the R-Smad
homotrmer is a function of increased energetic preference for its formation.
DISCUSSION
We have shown in the studies presented in this chapter that both the
Smad2/Smad4 and Smad3/Smad4 complexes are heterotrimers comprising two R-
Smad
subunits and one Smad4 subunit. This is the first strctural demonstration of the
heterotrmeric Smad assembly by X-ray crystallography. Strctual and fuctional
analysis of the Smad heterotrmer suggests that favorable electrostatic interactions 
within
the BC and AB interfaces playa significant role in the preferential formation of
heterotrmer over the R-Smad homotrimer. These electrostatic interactions can exist only
in the heterotrmer due to specific charged residues in the Smad4 subunit, Asp493 and
Arg378 , which mediate complementary electrostatic interactions with the neighboring R-
Smad subunits. Furermore , the unique conformation of Smad4, where the three-helix
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bundle strcture is tilted more towards the neighboring R-Smad subunit
, likely facilitates
better subunit-subunit contacts in the heterotrimer.
The stoichiometr of the heteromeric Smad complex and the strctual basis 
for
its preferential formation revealed here can likely be generalized to the Smad family of
proteins as a whole. Although only the TGF-beta and activin-specific Smads
, Smad2 and
Smad3 , are analyzed here , previous biochemical analysis of a BMP-specific Smad
Smadl , also revealed a 2:1 ratio between pseudophosphorylated Smadl and Smad4
(Chapter II; Qin et aI. , 2001). This hypothesis is supported by the structural similarity of
the R-Smads and the universal role of Smad4 as a common mediator in Smad signaling.
Furhermore, the residues in Smad2 and Smad 3 that form complementary electrostatic
interactions with Asp493 and Arg378 of Smad4 are identical in all R-Smads.
Although this study suggests a general model of heterotrimeric Smad assembly in
TGF-p signaling, the possibilty that other forms ofheteromeric Smad assembly can exist
in vivo in the presence of other signaling parters cannot be ruled out. For example
Inan and colleagues (Inman et aI. , 2002) have reported, using gel supershifting of
differentially tagged R-Smads by antibodies, that while the DNA-bound Smad2/Smad4
complex is a heterotrimer when bound to the co-factors Fast- l or Fast-
3, the
Smad3/Smad4 complex under similar conditions is a heterodimer. Also
, Jayaraman and
Massague reported, based on size-exclusion chromatography, that the endogenous
Smad2/Smad4 complex from TGF -p stimulated cells is heterodimeric. 
The difference in
these results from our own may represent a difference between the core R-
Smad/Smad4
complex, and one that has translocated into the nucleus and is bound to various cofactors.
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These results suggest the possibility that Smad cofactors , upon binding the R-
Smad/Smad4 complex in the nucleus , can disrupt the core heterotrmer in such a way that
one of the Smad subunits is knocked out, resulting in a Smad heterodimer. It has been
proposed that the transcription factor menin, which is known to interact with the MH2
domain ofSmad3 , might be an example of such a co-factor (Inan et aI. , 2002; Kaji et
aI. , 2001). The strctural homology with the interferon regulatory factor lAD domain
suggests that Smad MH2 domains may be able to interact with these domains, or with
other proteins containing FHA domains (Moustakas and Heldin, 2003). A recent report
has shown a direct physical interaction between Smad3 and IRF-7 (Qing et aI. , 2004),
raising the possibility that IRF - 7 might replace one of the Smad3 subunits to form a
Smad3/Smad4/IRF-7 complex, which would produce the Smad3/Smad4 heterodimer
observed by Inman and Hil (Inman and Hil, 2002). Finally, the FHA-containing protein
SNIP , which has been shown to interact with both Smadl and Smad2, may also be an
example of this type of protein (Kim et aI. , 2000). The strctural homology between the
Smad MH2 domain and the IRF lAD domain suggests the possibility that these domains
may also be able to interact.
It should also be noted that both immunoprecipitation and size exclusion analyses
are subject to potential artifact. The antibody approach assumes that the epitope tags are
all equally exposed. However, it is possible that lack of a supershift in the case of the
DNA bound Smad3/Smad4 complex may be the consequence of a tag being bured in the
DNA-bound transcriptional complex. The size-exclusion chromatography approach
alone, in general, cannot be used to unambiguously determine the oligomerization state
" ,
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as the result is affected by both the shape and the mass of the macromolecular complex.
Furer work is necessary to investigate the natue of novel heteromeric Smad
complexes , and the strctual basis for their assembly.
Given the apparent simplicity of the Smad system , it is intriguing that the TGF -ps
can mediate such a diversity of biological activity. The formation of a heterotrmeric
Smad complex consisting of two R-Smads and one Smad4 may provide part of the
answer, as this assembly mechanism greatly increases the potential diversity of the Smad
signaling system. From a strctual standpoint, it is feasible for the heterotrmeric Smad
complex to include two different R-Smad molecules , as the trimer interface among the R-
Smads is highly conserved. Such a combinatorial mechanism can greatly increase the
number of distinct signaling species with different Smad constitutions. Each of these
distinct Smad complexes may be able to perform different tasks, capable of recognizing
and activating of a specific set of gene promoters. This combinatorial mechanism of
Smad heterotrmerization is consistent with several biological observations , which have
shown that active Smad complexes can consist of more than one R-Smad (Nakao et aI.
1997; Labbe et aI. , 1998; Feng et aI. , 2000; Goumans et aI. , 2003).
Finally, Smad trimerization can also increase its specificity for promoter
recognition. The promoters ofTGF-p responsive genes generally contain Smad binding
elements (SBE), each recognized by the N-terminal MHI domain of an R-Smad or Smad
4 (Zawel et aI. , 1998; Shi et aI. , 1998). Smad2 is an exception since its MHI domain
contains an insertion that blocks DNA recognition. Thus, a heterotrmeric Smad complex
consisting of two R-Smads and one Smad4 can contain anywhere from one to three
f,''-
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fuctional DNA binding domains , depending on the number of Smad2 subunits present.
This combinatorial mechanism ofSmad assembly may explain in part why the TGF-p
responsive promoters contain different number of copies of SBE. The MHI domains
within the heterotrimeric Smad complex can also be at different relative distances to their
MH2 domains due to each Smad having a unique linker domain length. This asymmetric
propert of the heterotrimeric Smad complex may explain in part the different spacing of
SBE observed in the TGF-p responsive promoters. Futue studies on how different
heterotrmeric Smad complexes contact DNAs and transcriptional co-regulators wil
fuher clarfy the role of Smad trmerization in TGF -p signaling.
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CHAPTER V: GENERA DISCUSSION
This thesis examined the phosphorylation- induced R-Smad/Smad4 complex
which propagates the signals of the TGF -p family of ligands. The experiments in
Chapter II were designed to assess the stoichiometr ofR-Smad/Smad4 complexes
through the use of pseudo phosphorylated versions of two different R-Smads, Smad3 and
Smadl , in biochemical analyses. Smad3 is involved exclusively in TGF-p and activin
signaling, while Smadl paricipates only in BMP signaling. These two Smads were
chosen to determine whether mechanistic differences might exist between the TGF-
p/activin and BMP pathways. Constrcts of both proteins lacked the MHI domain
consisting only of the linker and MH2 domains. The Smad4 constrct used in these
experiments , S4AF, consisted of the MH2 domain and the C-terminal portion of the
linker domain, as this had been previously defined as the minimal Smad4 fragment
required to drve Smad-dependent transcription (de Caestecker et aI. , 2000a). As detailed
in Chapter II, size exclusion chromatography and analytical ultracentrfugation revealed
that both the Smad3/Smad4 and SmadllSmad4 complexes were heterotrmers, consisting
of2 R-Smad subunits and I Smad4 subunit. This result was later confirmed by ITC and
by crystallography of the Smad2/Smad4 and Smad3/Smad4 complexes. This is a
confirmation of the prior results ofKawabata and colleagues (Kawabata et aI. , 1998),
who determined that R-Smad/Smad4 complexes were heterotrmeric through
immunoprecipitation of epitope-tagged Smads. Our results contradict findings of
Jayaraman and Massague (Jayaraman and Massague, 2000), who analyzed Smad
complexes from TGF-p stimulated cells through size exclusion chromatography, and
if:;
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determined these complexes were heterodimers. More directly, our results contradict
studies by Wu and colleagues (Wu et aI. , 2001a; Wu et aI. , 2001b), who used similar size
exclusion chromatography and analytical ultracentrfugation analysis of purfied Smad
constrcts and found that the Smad2/Smad4 complex was a heterodimer. The primary
difference between these studies and our own was that Wu and colleagues used
unphosphorylated Smad2 constrcts , while our studies were done using
pseudophosphorylated versions ofSmad3 and Smadl. It is our opinion that the
heterodimer seen in the studies of Wu and colleagues was the formation of the
heteromeric BC interface, as described in Chapter IV. The electrostatic interactions at
this interface are so strong that parial complex formation can occur even in the absence
of phosphorylation. It appears that phosphorylation then allows the complex to fully
trmerize.
More recent analysis of the heteromeric R-Smad/Smad4 complex by Inman and
Hil produced contradictory results. Though immunoprecipitation of DNA-bound R-
Smad/Smad4 heteromers in complex with other transcriptional co-activators, they
determined that the Smad2/Smad4 complex was a heterotrmer (2 Smad2 to 1 Smad4),
while the Smad3/Smad4 complex was a heterodimer (Inman and Hil, 2002). We think 
is likely that this result reflects a difference between the core R-Smad/Smad4 complex
that forms immediately upon phosphorylation and the complex that activates transcription
in the nucleus. Much like Smad4 is able to knock out an R-Smad subunit out of the R-
Smad homotrmer to form the R-Smad/Smad4 heterotrmer, a nuclear co-factor might be
able to knock out another R-Smad subunit out of the heterotrmer to form a new R-
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Smad/Smad4/co-factor heterotrimer. Such a complex would appear to be a heterodimer
from the supershift analysis employed by Inman and Hil. Some potential candidates for
this type of co-factor include menin, which has been demonstrated to interact with the
Smad3 MH2 domain (Inman and Hil, 2002; Kaji et aI., 2001), and the interferon
regulatory factors (IRFs). IRF-7 has been demonstrated to directly interact with Smad3
(Qing et aI., 2004), and possesses a similar core p-strand sandwich to the Smad MH2
domain, which further supports the possibilty that this protein can replace an R-Smad
if'
subunit in the R-Smad/Smad4 heterotrmer.
The studies described in Chapter III were designed to determne a specific
mechanism for the phosphorylation-induced Smad trmer formation. It had been
established that par of the mechanism though which C-termnal phosphorylation effects
the activation of R-Smads is by decreasing the affinity of the MHI domain for the MH2
domain, thereby relieving autoinhibition (Hata et aI., 1997). However, it is also clear
from the experiments in Chapter II that phosphorylation also serves to energetically drve
the Smads toward trmerization. The constrcts used in the studies in Chapter II lacked
the autoinhibitory MHI domain, yet phosphorylation was stil required to fully effect
trmerization. Based on prior crystallographic analysis of Smad4(AF) (Qin et aI., 1999),
we proposed that phosphorylation might induce Smad trmerization by creating an
interaction between the phosphorylated C-terminal tails and positively-charged pockets
on adjacent Smads. This was confired by mutational analysis which revealed that
altering an arginine residue in the L3100p disrupted the heteromeric R-Smad/Smad4
interaction. Subsequent solution of a Smadl crystal strcture revealed that the C-
f/i
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termnal sites of serie phosphorylation were proximal to a basic surface defined by the
L3 loop and p8 strand, and supported the idea that C-termnal phosphorylation would
create favorable electrostatic interactions between the phosphorylated tail and basic
surface. Mutation of residues in the basic surface disrupted the heteromeric R-
Smad/Smad4 interaction and supported this notion. It is also noteworthy that the L3 loop
is a primar strctural mediator of R-Smad interaction with the receptor, and that a basic
surface defined parly by the L3 loop is responsible for interacting with the
phosphoserine residues on the GS domain of the receptor kinase, suggesting that the
Smad MH2 might be a general phosphoserine-binding domain. This was supported by
strctural comparson of the Smad MH2 to the FHA domain of Rad53 (Durocher et al.,
2000). The FHA domain is a known phosphoserine and phosphotheonine-binding
domain, and possesses a similar central p-strand sandwich as the Smad MH2.
Comparson of the strcture of homotrmeric Smadl with a SAR-bound (monomeric)
Smad2 revealed that the three-helix bundle and L3 loop assumed different conformations
between monomer and trmer, suggesting that phosphorylation may induce allosteric
strctural changes in R-Smads, allowing it to use a common basic surace to mediate
phospho serine-binding events with the receptor kinase and other Smads.
The strctural basis for the preferential formation of the R-Smad/Smad4
heterotrmer over the R-Smad homotrmer was addressed in Chapter IV. The crystal
strctures of the Smad2/Smad4 and Smad3/Smad4 complexes confIrmed the
stoichiometr that had been observed though other means, and also revealed that specific
residue differences between R-Smads and Smad4 led to the formation of highly favorable
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electrostatic interactions that result in the R-Smad/Smad4 heterotrmer being
energetically favored over the R-Smad homotrmer. Specifically, the presence of asparic
acid (D493) in helix 4 of Smad4, as opposed to a corresponding tyrosine residue in R-
Smads, results in highly favorable electrostatic interactions between the asparic acid
residue and four surounding arginine residues at the heterotrmeric BC interface. These
interactions at the BC interface are faciltated by a shift in the three-helix bundle of
Smad4 toward the neighboring helices in R-Smads. In addition, the presence of an
arginine residue (R378) in helix 1 of Smad4, replacing a methionine or leucine residue in
Smads, results in a novel interaction between helix 1 of Smad4 and the R-Smad
phosphorylated tail. Differential scanning calorimetr analysis revealed that Smad4 is a
considerably more thermostable protein than Smad3, and that the presence of Smad4 in
the complex raising the melting temperature of Smad3. This suggests another
mechanism for explaining how the R-Smad/Smad4 complex is energetically favored over
the R-Smad homotrmer; that the presence of Smad4 impars stabilty onto the R-Smad
subunits in the heterotrmeric complex.
There are many directions in which the research described herein can be logically
taken. The idea that a transcriptional co-activator can replace one of the R-Smad
subunits in the R-Smad/Smad4 heterotrmer is an exciting possibilty. It would be of
interest to determne the identity of these co-factors, and ultimately obtain strctural
knowledge of these R-Smad/Smad4/co-factor complexes. That others have seen
heterodimeric Smad complexes (Jayaraman and Massague, 2000; Inman and Hil, 2002)
presumes that this is the mechanism accounting for the existence of both heterotrmeric
;r.
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and heterodimeric Smad complexes, but it is possible that another mechanism may be
responsible, and it would be of interest to define whether another such mechanism exists.
Also , given that the L3100p has been implicated in both Smad binding to receptor (La et
aI. , 1998; Huse et aI. , 2001) and, from our work, in Smad/Smad interactions, it would be
intrguing to determine whether this same positively charged surace is responsible for
mediating other phospho serine-binding events. A strcture of an R-Smad/receptor
interaction would also be of interest, providing information about the mechanism though
which the L3 loop is able to allosterically direct these distinct binding events.
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